<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle - Witteveen, AGH - 2015 | Cochrane Library</title> <meta content="Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle - Witteveen, AGH - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010643.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle - Witteveen, AGH - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010643.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010643.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle" name="citation_title"/> <meta content="Angelique GH Witteveen" name="citation_author"/> <meta content="St Maartenskliniek" name="citation_author_institution"/> <meta content="agh.witteveen@hotmail.com" name="citation_author_email"/> <meta content="Cheriel J Hofstad" name="citation_author"/> <meta content="Sint Maartenskliniek" name="citation_author_institution"/> <meta content="Gino MMJ Kerkhoffs" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010643.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/10/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010643.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010643.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010643.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Ankle Joint; Botulinum Toxins [therapeutic use]; Exercise Therapy; Hyaluronic Acid [*therapeutic use]; Injections, Intra‐Articular; Osteoarthritis [*drug therapy]; Randomized Controlled Trials as Topic; Viscosupplements [*therapeutic use]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010643.pub2&amp;doi=10.1002/14651858.CD010643.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="9mpoajSI";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010643\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010643\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","hr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010643.pub2",title:"Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle",firstPublishedDate:"Oct 17, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010643.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010643.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010643.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010643.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010643.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010643.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010643.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010643.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010643.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010643.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8219 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010643.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0064"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0046"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-sec-0058"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/appendices#CD010643-sec-0069"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/table_n/CD010643StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/table_n/CD010643StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#CD010643-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Angelique GH Witteveen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#CD010643-cr-0003">Cheriel J Hofstad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information#CD010643-cr-0004">Gino MMJ Kerkhoffs</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information/en#CD010643-sec-0081">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 October 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010643.pub2">https://doi.org/10.1002/14651858.CD010643.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010643-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010643-abs-0009">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010643-abs-0001" lang="en"> <section id="CD010643-sec-0001"> <h3 class="title" id="CD010643-sec-0001">Background</h3> <p>The cause of ankle osteoarthritis (OA) is usually trauma. Patients are relatively young, since ankle trauma occurs at a relatively young age. Several conservative treatment options are available, evidence of the benefits and harms of these options are lacking. </p> </section> <section id="CD010643-sec-0002"> <h3 class="title" id="CD010643-sec-0002">Objectives</h3> <p>To assess the benefits and harms of any conservative treatment for ankle OA in adults in order to provide a synthesis of the evidence as a base for future treatment guidelines. </p> </section> <section id="CD010643-sec-0003"> <h3 class="title" id="CD010643-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2014, issue 9), MEDLINE (Ovid) (1946 up to 11 September 2014), EMBASE (1947 to September 2014), PsycINFO (1806 to September 2014), CINAHL (1985 to September 2014), PEDro (all years till September 2014), AMED until September 2014, ClinicalTrials.gov, Current Controlled Trials, The Dutch Register. To identify potentially relevant studies we screened reference lists in retrieved review articles and trials. </p> </section> <section id="CD010643-sec-0004"> <h3 class="title" id="CD010643-sec-0004">Selection criteria</h3> <p>We considered randomised or controlled clinical trials investigating any non‐surgical intervention for ankle OA for inclusion. </p> </section> <section id="CD010643-sec-0005"> <h3 class="title" id="CD010643-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD010643-sec-0006"> <h3 class="title" id="CD010643-sec-0006">Main results</h3> <p>No other RCT concerning any other conservative treatment besides the use of hyaluronic acid (HA) for ankle OA was identified. Six randomised controlled trials (RCTs) were included. </p> <p>A total of 240 participants diagnosed with ankle OA were included in this review. The primary analysis included three RCTs (109 participants) which compared HA to placebo. One study compared HA to exercise therapy, one compared HA combined with exercise therapy to an intra‐articular injection of botulinum toxin and one compared four different dosages of HA. </p> <p>Primary analysis: a pooled analysis of two trials (45 participants) found that the Ankle Osteoarthritis Scale (AOS) total score (measuring pain and physical function) was reduced by 12% (95% CI −24% to −1%) at six months (mean difference (MD) −12.53 (95% CI −23.84 to −1.22) on a scale of 0 to 100; number needed to treat for an additional beneficial outcome (NNTB) = 4 (95% CI 2 to 205); this evidence was graded as low quality, due to limitations in study design (unclear risk of selection bias for two studies and unclear risk for attrition bias for one study) and imprecision of results: a small population size (45 participants). It is not known if a mean difference of 12.53 points on a 100 point scale is clinically relevant. No minimal important clinical difference is known for this score. Pain and function outcomes were not reported separately. Radiographic joint structure changes were not investigated. For the mean quality of life at six months (two trials; 45 participants) no meta‐analysis could be performed due to missing data. No serious adverse events (SAEs) were noted and no participants withdrew because of an adverse event. There were a few adverse events (AEs) 5/63 (8%) in the HA group and 2/46 (4%) in the placebo group. The Peto odds ratio (Peto OR) to have an adverse event was 2.34 higher compared to the control group (95% CI 0.45 to 12.11). This evidence is inconclusive because of a wide CI and a small number of events. </p> <p>For comparing HA to exercise therapy (30 participants) the results for pain on a Visual Analogue Scale (VAS 0 to 10) at 12 months are inconclusive (MD 0.70, 95% CI −2.54 to 1.14). The American Orthopedic Foot and Ankle Society score (AOFAS score) was 13.10 points (MD) higher in favour of HA (95% CI 2.97 to 23.23) on a scale of 0 to 100. The evidence was graded as low. No adverse events were found. Radiographic structure changes were not measured; no participants withdrew due to AEs; no SAEs were found. </p> <p>For the comparison of HA injection combined with exercise therapy to an intra‐articular injection of botulinum toxin A (BoNT‐A) (75 participants), the outcome of the AOS pain score of the affected joint at six months is inconclusive (MD 0.10, 95% CI −0.42 to 0.62). The physical function (the AOS disability score) at six months is inconclusive (MD 0.20, 95% CI −0.34 to 0.74). The same number of AEs were found in both groups; HA 2/37 (5.9%), BoNT‐A 2/38 (5.8%) (risk ratio (RR) 1.03, 95% CI 0.15 to 6.91). Radiographic changes were not examined, no SAEs were found and no participants withdrew because of an AE. The evidence was graded as low. </p> <p>The RCT comparing four different dosing schedules for HA (26 participants) showed the best median decrease in pain on walking VAS (on a scale of 0 to 100) for 3 x 1 ml at 27 weeks with a median decrease of 30. Physical function, radiographic changes and quality of life were not measured.Twenty‐seven percent of all participants had AEs, most of them in the 2ml group (57% in this group). No participants withdrew due to an AE and no SAEs were noted. </p> <p>Overall the quality of the evidence showed some serious limitations. The evidence was graded low for the primary analysis comparing HA to placebo. This was based on a limitation in design and implementation: sample sizes were small (45 to 92 participants) and and imprecision in results: there was an unclear risk of bias for several items concerning the three studies used in the meta analysis. </p> </section> <section id="CD010643-sec-0007"> <h3 class="title" id="CD010643-sec-0007">Authors' conclusions</h3> <p>Currently, there is insufficient data to create a synthesis of the evidence as a base for future guidelines for ankle OA. Since the aetiology of ankle OA is different, guidelines that are currently used for hip and knee OA may not be applicable for ankle OA. Simple analgesics as recommended for hip and knee OA seem however a reasonable first step to treat ankle OA. It is unclear if there is a benefit or harm for HA as treatment for ankle OA compared to placebo at six months based on a low quality of evidence. Inconclusive results were found comparing HA to other treatments. HA can be conditionally recommended if patients have an inadequate response to simple analgesics. It remains unclear which patients (age, grade of ankle OA) benefit the most from HA injections and which dosage schedule should be used. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010643-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD010643-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010643-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010643-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/pl#CD010643-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD010643-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010643-abs-0003" lang="en"> <h3>Hyaluronic acid and other non‐surgical treatment options for ankle osteoarthritis</h3> <p>Cochrane researchers conducted a review of the effect of non‐surgical treatment for people older than 18 with ankle osteoarthritis in order to provide a synthesis of the evidence as a base for future treatment guidelines. After searching for all relevant studies up to September 2014, no study using any other non‐surgical treatment besides the use of hyaluronic acid for ankle osteoarthritis was identified. They found six studies evaluating hyaluronic acid with a total of 240 people. Their findings are summarised below: </p> <p>Five studies showed the results of the use of hyaluronic acid for ankle osteoarthritis compared to other treatment (exercise (30 people) or botulinum toxin A injections (75 people) or to placebo (fake injection) (3 studies, 109 people). One study was a dose‐finding study (26 people). Follow‐up was three to six months. The quality of the evidence was graded as low, due to an unclear risk of bias and a low number of participants. </p> <p><b>In people with ankle osteoarthritis:</b> </p> <p>‐ No studies were identified to support the use of any other non‐surgical treatment.</p> <p>‐ We are uncertain if there is a benefit of hyaluronic acid for the treatment of ankle osteoarthritis compared to placebo. </p> <p>‐ Results comparing hyaluronic acid to other treatment are inconclusive.</p> <p>‐ Results about the best dosing schedule for hyaluronic acid are inconclusive.</p> <p>‐ Possible side effects of hyaluronic acid might include swelling and pain of the joint which subsides within a couple of days. </p> <p>‐ Hyaluronic acid injections might be conditionally recommended when simple analgesics have failed. </p> <p><b>What is osteoarthritis, what is hyaluronic acid and what other non‐surgical treatment options are there?</b> </p> <p>Osteoarthritis (OA) is a disease of the joints. When the joint loses cartilage, the bone grows to try to repair the damage. Instead of making things better, however, the bone grows abnormally and makes things worse. For example, the bone can become misshapen and make the joint painful and unstable. This can affect your physical function or ability to use your ankle. </p> <p>Hyaluronic acid is a natural component of synovial fluid. Hyaluronic acid injections (also called 'viscosupplementation') are gel‐like fluid injections which help to lubricate the joint and act as a shock absorber for joint loads. These injections are used in a hospital environment when simple analgesics have failed. </p> <p>Other non‐surgical options for ankle OA are, for instance, the use of different types of analgesics and the use of non‐pharmacological therapy like shoe adjustments, braces, weight loss and exercises or a combination of any of those. </p> <p><b>What happens to people with ankle osteoarthritis who get injections with hyaluronic acid compared to placebo?</b> </p> <p>After six months (45 people) pain and physical function were measured using a combined score (scale of 0 to 100; 0 is the best score and 100 the worst): </p> <p>‐ People who got injections with hyaluronic acid rated their pain and physical function 12.3 points lower compared to placebo (12% absolute improvement). </p> <p>‐ People who got injections with hyaluronic acid rated their pain and physical function 24.4 points lower. </p> <p>‐ People who got injections with placebo rated their pain and physical function 12.1 points lower. </p> <p><b>Radiographic joint structure changes:</b> </p> <p>‐ No studies were found that looked at this outcome.</p> <p><b>Quality of life:</b> </p> <p>‐ No data is available to make a statement about quality of life.</p> <p><b>Number of people experiencing any serious adverse events (109 people):</b> </p> <p>‐ No patient in either group experienced a serious adverse event.</p> <p><b>Number of people experiencing any adverse event (109 people):</b> </p> <p>‐ 35 more people per 1000 who are treated with hyaluronic acid will experience an adverse event compared to placebo (3.5% absolute increase). </p> <p>‐ 78 people per 1000 who are treated with hyaluronic acid will experience an adverse event. </p> <p>‐ 43 people per 1000 who are treated with placebo will experience an adverse event.</p> <p><b>People who withdraw because of an adverse event (109 people):</b> </p> <p>‐ No participants withdrew in either group.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010643-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-sec-0064">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-sec-0106">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010643-sec-0064"></div> <h3 class="title" id="CD010643-sec-0065">Implications for practice</h3> <section id="CD010643-sec-0065"> <p>Currently, there is insufficient data to create a synthesis of the evidence as a base for future guidelines for ankle osteoarthritis. Since the aetiology of ankle OA is different, guidelines that are currently used for hip and knee OA may not be applicable for ankle OA. Simple analgesics as recommended for hip and knee OA seem, however, a reasonable first step to treat ankle OA. It is unclear if there is a benefit or harm for HA as treatment for ankle OA compared to placebo at six months based on a low quality of evidence. Inconclusive results were found comparing HA to other treatments. HA can be conditionally recommended if patients have an inadequate response to simple analgesics. It remains unclear which patients (age, grade of ankle OA) benefit the most from HA injections and which dosage schedule should be used. </p> </section> <h3 class="title" id="CD010643-sec-0066">Implications for research</h3> <section id="CD010643-sec-0066"> <p>To find evidence for conservative treatment of ankle OA current treatment possibilities, as described in the background section, should be tested against placebo in well‐conducted randomised controlled trials. Treatment should be tested for age and grade of osteoarthritis. Dosage schedules for medication should be optimised and tested in RCTs. Validated participant‐ and doctor‐based outcome parameters should be used. Pain and function improvement could be relevant: these parameters can be measured by outcome measures as described in the Method section. Radiographic changes can be important to monitor or to evaluate the radiographic progression of osteoarthritis. Evaluation of evidence from different RCTs in combination with the experience from the different specialists in the field of OA, as well as participants' experiences can lead to a useful guideline for treatment of ankle OA. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010643-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010643-sec-0015"></div> <div class="table" id="CD010643-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyaluronic acid for osteoarthritis of the ankle</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyaluronic acid for osteoarthritis of the ankle</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with osteoarthritis of the ankle<br/> <b>Settings:</b> Rehabilitation centre / hospital<br/> <b>Intervention:</b> hyaluronic acid<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Hyaluronic acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>AOS total (Pain &amp; Physical function)</b> <br/> AOS total score. Scale from: 0 to 100 (0 = being no pain/disability, 100 = worst imaginable pain/disability).<br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain/physical function change ranged across the control groups from 6.8 to 20.9 points lower with a weighted mean of<br/> <b>12.14 lower</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain/physical function in the hyaluronic acid group was <b>12.53 points lower</b> (23.84 lower to 1.22 lower) compared to placebo at 6 months. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score indicates less pain and a better physical function. It is not known if a change of 12 points is clinically relevant. </p> <p>NNT = 4 (95% CI 2 to 205) (using a SMD = 0.5 as a minimum important difference).</p> <p>Absolute risk difference is −12.53% (95% CI −23.84 to −1.22).</p> <p>Relative percentage change is 1.85% (95% CI 0.18 to 3.58%).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiographic Joint Structure Changes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Radiographic joint structure changes were not investigated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of Life</b> </p> <p>SF12. Scale from: 0 to 100. Follow‐up: mean 6 months.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cohen 2008 only described that there was no significant difference between placebo and intervention for the SF12 outcome, no exact data was provided. </p> <p>Salk 2006 could not provide us with the standard deviations, so no estimate of the SF12 could be made. He demonstrated a statistically significant difference in his paper favouring hyaluronic acid at 6 months. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing any serious adverse events</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events (SAEs) were noted</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing any adverse event</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> <br/> <b>higher</b> (26 fewer to 241 more) compared to placebo. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.66</b> <br/> (0.47 to 5.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peto Odds Ratio is 2.34</p> <p>(95% CI 0.45 to 12.11)</p> <p>Absolute risk difference is 5.00% (−5 to 14), relative percentage change is 66% (−53% to 488%). </p> <p>Adverse events for all 3 studies were reported, even though DeGroot had a follow up of 3 months. All adverse events resolved within a week after injection, so a shorter follow up has no effect on the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants who withdraw because of an adverse event or any other reason</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No participants withdrew because of an adverse event</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>AOS:</b> Ankle Osteoarthritis Scale<b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>SF12:</b> short form 12 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>Grade criteria</b>: study limitation, indirectness, inconsistency, imprecision, publication bias. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>* The assumed risk was based on the weighted mean of the scores in the control groups across the 2 studies. The range was based on the mean change in pain on a visual analogue scale (100 mm) of the control group in each separate study.The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><sup>1</sup> Evidence was downgraded based on limitations in study design and imprecision of results. Limitation in study design: there was a unclear risk of selection bias for Salk and Cohen, unclear risk for attrition bias for Salk. Imprecision of results: the population size is small (45 participants). No indirectness of evidence was found, no inconsistency and no publication bias. </p> <p><sup>2</sup> Evidence was downgraded based on limitations in study design and imprecision of results. Limitation in study design: there was a unclear risk of selection bias for Cohen, an unclear risk for reporting bias for DeGroot. Imprecision of results: the total population size is small (92 participants). No indirectness of evidence was found, no inconsistency and no publication bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010643-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-sec-0016">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-sec-0086">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010643-sec-0016"></div> <section id="CD010643-sec-0017"> <h3 class="title" id="CD010643-sec-0017">Description of the condition</h3> <p>Osteoarthritis (OA) is a chronic and degenerative disorder associated with joint pain and loss of joint function. OA can affect any synovial joint but is found most frequently in the hip, knee and hand; the majority of these patients present with primary OA (idiopathic disease) (<a href="./references#CD010643-bbs2-0023" title="BuckwalterJA , SaltzmanC , BrownT . The impact of osteoarthritis: implications for research. Clinical Orthopaedics and Related Research2004;427 Suppl:S6‐15. ">Buckwalter 2004</a>; <a href="./references#CD010643-bbs2-0041" title="KalunianKC . Nonpharmacologic therapy of osteoarthritis. In: TugwellP , RomainPL editor(s). UpToDate. Waltham, MA (USA): UpToDate, 2012. ">Kalunian 2012</a>; <a href="./references#CD010643-bbs2-0013" title="WitteveenAG , GianniniS , GuidoG , JeroschJ , LohrerH , VanniniF , et al. A prospective multi‐centre, open study of the safety and efficacy of hylan G‐F 20 (Synvisc) in patients with symptomatic ankle (talo‐crural) osteoarthritis. Foot and Ankle Surgery2008;14(3):145‐52. ">Witteveen 2008</a>). Reliable figures on the prevalence of OA in other joints are not readily available but estimates suggest that the incidence of symptomatic ankle OA is 1% to 4% in the adult population (<a href="./references#CD010643-bbs2-0028" title="CushnaghanJ , DieppeP . Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Annals of the Rheumatic Diseases1991;50(1):8‐13. ">Cushnaghan 1991</a>; <a href="./references#CD010643-bbs2-0056" title="PeyronJG . The epidemiology of osteoarthritis. In: MoskowitzRW , HowellDS , GoldbergVM , MankinHS editor(s). Osteoarthritis: diagnosis and management. Philadelphia and London: Saunders, 1984:9‐27. ">Peyron 1984</a>). In contrast to knee and hip OA, 70% to 78% of people with ankle OA present with secondary, post‐traumatic disease (sequelae after ankle fracture, ankle instability or fracture of the lower leg); the remainder is primary OA as well as inflammatory diseases, such as rheumatoid arthritis and gout (<a href="./references#CD010643-bbs2-0064" title="SaltzmanCL , SalamonML , BlanchardGM , HuffT , HayesA , BuckwalterJA , et al. Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic centre. The Iowa Orthopaedic Journal2005;25:44‐6. ">Saltzman 2005</a>; <a href="./references#CD010643-bbs2-0074" title="ValderrabanoV , HorisbergerM , Russell , I , DougallH , HintermannB . Etiology of ankle osteoarthritis. Clinical Orthopaedics and Related Research2009;476(7):1800‐6. ">Valderrabano 2009</a>). Ankle trauma occurs in many people at a relatively young age (<a href="./references#CD010643-bbs2-0015" title="AgelJ , CoetzeeJC , SangeorzanBJ , RobertsMM , Hansen JrST . Functional limitations of patients with end‐stage ankle arthrosis. Foot and Ankle International2005;26:537‐9. ">Agel 2005</a>; <a href="./references#CD010643-bbs2-0064" title="SaltzmanCL , SalamonML , BlanchardGM , HuffT , HayesA , BuckwalterJA , et al. Epidemiology of ankle arthritis: report of a consecutive series of 639 patients from a tertiary orthopaedic centre. The Iowa Orthopaedic Journal2005;25:44‐6. ">Saltzman 2005</a>). Consequently, the expected life span of many people with ankle OA is significantly longer than the life span of hip or knee OA patients; this affects their quality of life for a substantial length of time. <a href="./references#CD010643-bbs2-0065" title="SaltzmanCL , ZimmermanMB , O'RourkeM , BrownTD , BuckwalterJA , JohnstonR . Impact of comorbidities on the measurement of health in patients with ankle osteoarthritis. Journal of Bone and Joint Surgery. American Volume2006;88(11):2366‐72. ">Saltzman 2006</a> demonstrated that the self reported physical function in people with symptomatic ankle OA quantified using the Short Form‐36 (SF‐36) questionnaire was equivalent to or worse than that of patients with end‐stage kidney disease or congestive heart failure suggesting that these people are seriously impaired. </p> </section> <section id="CD010643-sec-0018"> <h3 class="title" id="CD010643-sec-0018">Description of the intervention</h3> <p>In clinical practice, patients diagnosed with end‐stage ankle OA (Kellgren Lawrence 3 or 4 and van Dijk 3) are offered operative treatment if they have significant clinical symptoms (<a href="./references#CD010643-bbs2-0036" title="HaradaY , TokudaO , FukudaK , ShiraishiG , MotomuraT , KimuraM , et al. Relationship between cartilage volume using MRI and Kellgren‐Lawrence radiographic score in knee osteoarthritis with and without meniscal tears. American Journal of Roentgenology2011;196(3):W298‐304. ">Harada 2011</a>; <a href="./references#CD010643-bbs2-0075" title="vanDijkCN , TolJL , VerheyenCC . A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. American Journal of Sports Medicine1997;25(6):737‐45. ">van Dijk 1997</a>). These people are treated by arthrodesis, ankle replacement or osteotomy. Surgical treatment is specifically reserved for end‐stage arthritis. It is considered to be controversial due to short‐ and long‐term complications. Complications consist of wound healing problems, infectious disease, non‐ or delayed union and OA of adjacent joints due to overloading (<a href="./references#CD010643-bbs2-0027" title="ChangKV , HsiaoMY , ChenWS , WangTG , ChienKL . Effectiveness of intra‐articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta‐analysis. Archives of Physical Medicine and Rehabilitation2013;94(5):951‐60. ">Chang 2013</a>; <a href="./references#CD010643-bbs2-0030" title="DeorioJK , EasleyME . Total ankle arthroplasty. Instructional Course Lectures2008;57:383‐413. ">Deorio 2008</a>; <a href="./references#CD010643-bbs2-0040" title="JungHG , ParksBG , NguyenA , SchonLC . Effect of tibiotalar joint arthrodesis on adjacent tarsal joint pressure in a cadaver model. Foot &amp; Ankle International2007;28(1):103‐8. ">Jung 2007</a>; <a href="./references#CD010643-bbs2-0046" title="KrauseFG , SchmidT . Ankle arthrodesis versus total ankle replacement: how do I decide?. Foot and Ankle Clinics2012;17(4):529‐43. ">Krause 2012</a>; <a href="./references#CD010643-bbs2-0060" title="RippsteinPF , HuberM , NaalFD . Management of specific complications related to total ankle arthroplasty. Foot and Ankle Clinics2012;17(4):707‐17. ">Rippstein 2012</a>; <a href="./references#CD010643-bbs2-0068" title="SuckelA , BurgerA , WülkerN , WünschelM . Ankle arthrodesis ‐ clinical, radiological and biomechanical aspects with special regard to the adjacent joints. Zeitschrift für Orthopädie und Unfallchirurgie2012;150(6):588‐93. ">Suckel 2012</a>). Complication rates vary up to 44% depending on the type of surgery; and the type of complication — short‐ or long‐term. OA of adjacent joints after ankle arthrodesis occurs for instance in 44% to 50% of cases after 20 years (<a href="./references#CD010643-bbs2-0051" title="MorreyBF , WiedemanGP . Complications and long‐term results of ankle arthrodeses following trauma. The Journal of Bone and Joint Surgery, American Volume1980;62(5):777‐84. ">Morrey 1980</a>; <a href="./references#CD010643-bbs2-0054" title="PagenstertG , LeumannA , HintermannB , ValderrabanoV . Sports and Recreation Activity of Varus and Valgus Ankle Osteoarthritis Before and After Realignment Surgery. Foot &amp; Ankle International2008;29(10):985‐93. ">Pagenstert 2008</a>; <a href="./references#CD010643-bbs2-0069" title="TakakuraY , TanakaY , SugimotoK , AkiyamaK , TamaiS . Long‐term results of arthrodesis for osteoarthritis of the ankle. Clinical Orthopaedics and Related Research1999;361:178‐85. ">Takakura 1995</a>). Operative treatment is therefore not considered in an early phase of OA and it remains a challenge to treat people that are diagnosed with a low grade OA of the ankle (Kellgren Lawrence 1, 2, or 3 and Van Dijk 1 or 2) (<a href="./references#CD010643-bbs2-0036" title="HaradaY , TokudaO , FukudaK , ShiraishiG , MotomuraT , KimuraM , et al. Relationship between cartilage volume using MRI and Kellgren‐Lawrence radiographic score in knee osteoarthritis with and without meniscal tears. American Journal of Roentgenology2011;196(3):W298‐304. ">Harada 2011</a>; <a href="./references#CD010643-bbs2-0075" title="vanDijkCN , TolJL , VerheyenCC . A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. American Journal of Sports Medicine1997;25(6):737‐45. ">van Dijk 1997</a>). They are young and they experience serious disabilities which prevent them from participating in more heavily physical work as well as sports activities. Several conservative treatment options are available; however evidence of the benefits and harms of these options are lacking. </p> <p>The conservative treatment of symptomatic ankle OA, like general OA, consists mainly of treating symptoms like pain and stiffness. Since no cure is available at this point another treatment goal is preventing deterioration of the joint (<a href="./references#CD010643-bbs2-0073" title="TowheedT , MaxwellL , JuddM , CattonM , HochbergMC , WellsGA . Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004257.pub2] ">Towheed 2006</a>). Non‐pharmacological therapy is to be considered the foundation for the successful medical management of general OA (<a href="./references#CD010643-bbs2-0038" title="HochbergMC , AltmanRD , AprilKT , BenkhaltiM , GuyattG , McGowanJ , et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care &amp; Research2012;64(4):465‐74. ">Hochberg 2012</a>; <a href="./references#CD010643-bbs2-0079" title="ZhangW , MoskowitzRW , NukiG , AbramsonS , AltmanRD , ArdenN , et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence‐based, expert consensus guidelines. Osteoarthritis and Cartilage2008;16(2):137‐62. ">Zhang 2008</a>; <a href="./references#CD010643-bbs2-0080" title="ZhangW , NukiG , MoskowitzRW , AbramsonS , AltmanRD , ArdenNK , et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage2010;18(4):476‐99. ">Zhang 2010</a>). There are systematic reviews published for knee and hip OA and include weight reduction (BMI &gt; 25), physiotherapy and occupational therapy (<a href="./references#CD010643-bbs2-0021" title="BrosseauL , YongeK , WelchV , MarchandS , JuddM , WellsGA , et al. Thermotherapy (heat treatment) for treating osteoarthritis of the knee. Cochrane Database of Systematic Reviews2003, Issue 4. [DOI: 10.1002/14651858.CD004522] ">Brosseau 2011</a>; <a href="./references#CD010643-bbs2-0022" title="BrouwerRW , vanRaaijTM , JakmaTT , VerhagenAP , VerhaarJAN , Bierma‐ZeinstraSMA . Braces and orthoses for treating osteoarthritis of the knee. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD004020.pub2] ">Brouwer 2005</a>; <a href="./references#CD010643-bbs2-0062" title="RutjesAWS , NüeschE , SterchiR , KalichmanL , HendriksE , OsiriM , et al. Transcutaneous electrostimulation for osteoarthritis of the knee. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002823.pub2] ">Rutjes 2009</a>; <a href="./references#CD010643-bbs2-0063" title="RutjesAWS , NüeschE , SterchiR , JüniP . Therapeutic ultrasound for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews2010, Issue 1. [DOI: 10.1002/14651858.CD003132.pub2] ">Rutjes 2010</a>). For ankle OA, offloading the joint by brace, cane, rocker sole or inlay is commonly used in clinical practice to reduce pain; however no evidence is available to support this treatment (<a href="./references#CD010643-bbs2-0017" title="BartelsEM , LundH , HagenKB , DagfinrudK , ChristensenR , Danneskiold‐SamsøeB . Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005523.pub2] ">Bartels 2007</a>; <a href="./references#CD010643-bbs2-0020" title="BrosseauL , MacLeayL , WelchV , TugwellP , WellsGA . Intensity of exercise for the treatment of osteoarthritis. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD004259.pub2] ">Brosseau 2003</a>; <a href="./references#CD010643-bbs2-0032" title="FransenM , McConnellS , Hernandez‐MolinaG , ReichenbachS . Exercise for osteoarthritis of the hip. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007912] ">Fransen 2009</a>; <a href="./references#CD010643-bbs2-0039" title="JanisseDJ . Prescription footwear for arthritis of the foot and ankle. Clinical Orthopaedics and Related Research1998;349:100‐7. ">Janisse 1998</a>; <a href="./references#CD010643-bbs2-0044" title="KempsonGE . Age‐related changes in the tensile properties of human articular cartilage: a comparative study between the femoral head of the hip joint and the talus of the ankle joint. Biochimica et Biophysica Acta1991;1075(3):223‐30. ">Kempson 1991</a>; <a href="./references#CD010643-bbs2-0049" title="MessierSP , GutekunstDJ , DavisC , DeVitaP . Weight loss reduces knee‐joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis and Rheumatism2005;52(7):2026‐32. ">Messier 2005</a>; <a href="./references#CD010643-bbs2-0048" title="McGuireJB . Arthritis and related diseases of the foot and ankle: rehabilitation and biomechanical considerations. Clinics in Podiatric Medicine and Surgery2003;20(3):469‐85, ix. ">McGuire 2003</a>; <a href="./references#CD010643-bbs2-0078" title="WuWL , RosenbaumD , SUFC . The effects of rocker sole and SACH heel on kinematics in gait. Medical Engineering and Physics2004;26:639‐46. ">Wu 2004</a>). If this non‐pharmacological treatment is not successful a painkiller can be added. Several pain relief options are available, e.g. painkillers like acetaminophen, opioids and non‐steroidal anti‐inflammatory drugs (NSAIDs) (<a href="./references#CD010643-bbs2-0026" title="CepedaMS , CamargoF , ZeaC , ValenciaL . Tramadol for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD005522.pub2] ">Cepeda 2006</a>; <a href="./references#CD010643-bbs2-0033" title="GarnerSE , FidanD , FrankishRR , MaxwellL . Rofecoxib for osteoarthritis. Cochrane Database of Systematic Reviews2005, Issue 1. [DOI: 10.1002/14651858.CD005115] ">Garner 2005</a>; <a href="./references#CD010643-bbs2-0052" title="NüeschE , RutjesAWS , HusniE , WelchV , JüniP . Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD003115.pub3] ">Nuesch 2010</a>; <a href="./references#CD010643-bbs2-0073" title="TowheedT , MaxwellL , JuddM , CattonM , HochbergMC , WellsGA . Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004257.pub2] ">Towheed 2006</a>). Hyaluronic acid (HA) for ankle OA has been shown to reduce pain as well. HA is currently used in clinical practice when simple analgesics have failed (<a href="./references#CD010643-bbs2-0027" title="ChangKV , HsiaoMY , ChenWS , WangTG , ChienKL . Effectiveness of intra‐articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta‐analysis. Archives of Physical Medicine and Rehabilitation2013;94(5):951‐60. ">Chang 2013</a>; <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0057" title="PleimannJH , DavisWH , CohenBE , AndersonRB . Viscosupplementation for the arthritic ankle. Foot and Ankle Clinics2002;7(3):489‐94. ">Pleimann 2002</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>; <a href="./references#CD010643-bbs2-0011" title="SunSF , ChouYJ , HsuCW , HwangCW , HsuPT , WangJL , et al. Efficacy of intra‐articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis and Cartilage2006;14:867‐74. ">Sun 2006</a>; <a href="./references#CD010643-bbs2-0013" title="WitteveenAG , GianniniS , GuidoG , JeroschJ , LohrerH , VanniniF , et al. A prospective multi‐centre, open study of the safety and efficacy of hylan G‐F 20 (Synvisc) in patients with symptomatic ankle (talo‐crural) osteoarthritis. Foot and Ankle Surgery2008;14(3):145‐52. ">Witteveen 2008</a>; <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a>). The benefit of glucosamine/chondroitin for pain reduction in general OA was not shown (<a href="./references#CD010643-bbs2-0072" title="TowheedTE , MaxwellL , AnastassiadesTP , SheaB , HouptJ , WelchV , et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002946.pub2] ">Towheed 2005</a>). </p> </section> <section id="CD010643-sec-0019"> <h3 class="title" id="CD010643-sec-0019">How the intervention might work</h3> <p>Ankle OA pain might be reduced by offloading the joint through rest, wearing a brace or using a cane. A cane can reduce the amount of bodyweight going through the ankle joint by 25% (<a href="./references#CD010643-bbs2-0044" title="KempsonGE . Age‐related changes in the tensile properties of human articular cartilage: a comparative study between the femoral head of the hip joint and the talus of the ankle joint. Biochimica et Biophysica Acta1991;1075(3):223‐30. ">Kempson 1991</a>). Rocker soles are thought to offload the ankle joint by decreasing the ankle motion at heel strike to push off during walking (<a href="./references#CD010643-bbs2-0078" title="WuWL , RosenbaumD , SUFC . The effects of rocker sole and SACH heel on kinematics in gait. Medical Engineering and Physics2004;26:639‐46. ">Wu 2004</a>). Weight loss by dietary adjustments or exercises are thought to offload a joint as well (<a href="./references#CD010643-bbs2-0017" title="BartelsEM , LundH , HagenKB , DagfinrudK , ChristensenR , Danneskiold‐SamsøeB . Aquatic exercise for the treatment of knee and hip osteoarthritis. Cochrane Database of Systematic Reviews2007, Issue 4. [DOI: 10.1002/14651858.CD005523.pub2] ">Bartels 2007</a>; <a href="./references#CD010643-bbs2-0020" title="BrosseauL , MacLeayL , WelchV , TugwellP , WellsGA . Intensity of exercise for the treatment of osteoarthritis. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD004259.pub2] ">Brosseau 2003</a>; <a href="./references#CD010643-bbs2-0032" title="FransenM , McConnellS , Hernandez‐MolinaG , ReichenbachS . Exercise for osteoarthritis of the hip. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD007912] ">Fransen 2009</a>). In <a href="./references#CD010643-bbs2-0049" title="MessierSP , GutekunstDJ , DavisC , DeVitaP . Weight loss reduces knee‐joint loads in overweight and obese older adults with knee osteoarthritis. Arthritis and Rheumatism2005;52(7):2026‐32. ">Messier 2005</a>, each pound of weight loss created a 4‐fold reduction in the load exerted by step at the knee during daily activities. Shoe adjustment like inlays can correct alignment issues and in this way offload a part of the joint thus creating pain reduction (<a href="./references#CD010643-bbs2-0039" title="JanisseDJ . Prescription footwear for arthritis of the foot and ankle. Clinical Orthopaedics and Related Research1998;349:100‐7. ">Janisse 1998</a>; <a href="./references#CD010643-bbs2-0048" title="McGuireJB . Arthritis and related diseases of the foot and ankle: rehabilitation and biomechanical considerations. Clinics in Podiatric Medicine and Surgery2003;20(3):469‐85, ix. ">McGuire 2003</a>). It is possible that in this way the joint can be preserved from further deterioration. Several analgesics are available like acetaminophen, opioids and NSAIDs. They either act as a simple analgesic, have anti‐inflammatory effects, a sedative effect or a combination of these. Recommendations for hip, knee or hand OA are well described (<a href="./references#CD010643-bbs2-0038" title="HochbergMC , AltmanRD , AprilKT , BenkhaltiM , GuyattG , McGowanJ , et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care &amp; Research2012;64(4):465‐74. ">Hochberg 2012</a>). Hyaluronic acid (viscosupplementation) is thought to restore rheologic properties of the joint by creating a more viscoelastic synovial fluid which improves mobility and restores the natural protective function of the joint, like shock absorption during gait (<a href="./references#CD010643-bbs2-0016" title="BalazsEA . Viscosupplementation: a new concept in the treatment of osteoarthritis. The Journal of Rheumatology. Supplement1993;39:3‐9. ">Balazs 1993</a>; <a href="./references#CD010643-bbs2-0019" title="BellamyN , CampbellJ , WelchV , GeeTL , BourneR , WellsGA . Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD005321.pub2] ">Bellamy 2006</a>). Several studies have suggested pain reduction as well (<a href="./references#CD010643-bbs2-0027" title="ChangKV , HsiaoMY , ChenWS , WangTG , ChienKL . Effectiveness of intra‐articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta‐analysis. Archives of Physical Medicine and Rehabilitation2013;94(5):951‐60. ">Chang 2013</a>; <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0057" title="PleimannJH , DavisWH , CohenBE , AndersonRB . Viscosupplementation for the arthritic ankle. Foot and Ankle Clinics2002;7(3):489‐94. ">Pleimann 2002</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>; <a href="./references#CD010643-bbs2-0011" title="SunSF , ChouYJ , HsuCW , HwangCW , HsuPT , WangJL , et al. Efficacy of intra‐articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis and Cartilage2006;14:867‐74. ">Sun 2006</a>; <a href="./references#CD010643-bbs2-0013" title="WitteveenAG , GianniniS , GuidoG , JeroschJ , LohrerH , VanniniF , et al. A prospective multi‐centre, open study of the safety and efficacy of hylan G‐F 20 (Synvisc) in patients with symptomatic ankle (talo‐crural) osteoarthritis. Foot and Ankle Surgery2008;14(3):145‐52. ">Witteveen 2008</a>; <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a>). Glucosamine/chondroitin may be potentially chondro‐protective and may modify the progression and course of general OA, though improvement in pain and function are not conclusive (<a href="./references#CD010643-bbs2-0067" title="SinghJA , NoorbaloochiS , MacDonaldR , MaxwellLJ . Chondroitin for osteoarthritis. Cochrane Database of Systematic Reviews2015, Issue 1. [CENTRAL: Art. No.: CD005614; DOI: 10.1002/14651858.CD005614.pub2] ">Singh 2015</a>; <a href="./references#CD010643-bbs2-0072" title="TowheedTE , MaxwellL , AnastassiadesTP , SheaB , HouptJ , WelchV , et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002946.pub2] ">Towheed 2005</a>). </p> </section> <section id="CD010643-sec-0020"> <h3 class="title" id="CD010643-sec-0020">Why it is important to do this review</h3> <p>Lots of treatment modalities are offered, however no clear‐cut treatment algorithm for ankle OA is used in clinical practice. The choice of treatment depends on the severity of the disease; the person's age, medical and social history; and the level of physical activity expected to be demanded of the joint. For knee and hip OA several treatment algorithms are advocated (<a href="./references#CD010643-bbs2-0041" title="KalunianKC . Nonpharmacologic therapy of osteoarthritis. In: TugwellP , RomainPL editor(s). UpToDate. Waltham, MA (USA): UpToDate, 2012. ">Kalunian 2012</a>; <a href="./references#CD010643-bbs2-0055" title="PendletonA , ArdenN , DougadosM , DohertyM , BannwarthB , BijlsmaJW , et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases2000;59(12):936‐44. ">Pendleton 2000</a>; <a href="./references#CD010643-bbs2-0070" title="TannenbaumH , PelosoPM , RussellAS , MarlowB . An evidence based approach to prescribing NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: the second Canadian Consensus Conference. Canadian Journal of Clinical Pharmacology2000;7 Suppl A:4A‐16A. ">Tannenbaum 2000</a>; <a href="./references#CD010643-bbs2-0072" title="TowheedTE , MaxwellL , AnastassiadesTP , SheaB , HouptJ , WelchV , et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD002946.pub2] ">Towheed 2005</a>; <a href="./references#CD010643-bbs2-0073" title="TowheedT , MaxwellL , JuddM , CattonM , HochbergMC , WellsGA . Acetaminophen for osteoarthritis. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD004257.pub2] ">Towheed 2006</a>; <a href="./references#CD010643-bbs2-0079" title="ZhangW , MoskowitzRW , NukiG , AbramsonS , AltmanRD , ArdenN , et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence‐based, expert consensus guidelines. Osteoarthritis and Cartilage2008;16(2):137‐62. ">Zhang 2008</a>; <a href="./references#CD010643-bbs2-0080" title="ZhangW , NukiG , MoskowitzRW , AbramsonS , AltmanRD , ArdenNK , et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and Cartilage2010;18(4):476‐99. ">Zhang 2010</a>). However, since ankle OA may be caused by a different mechanism, it is not unthinkable that these patients need a different treatment. </p> <p>At this point there is no evidence‐based treatment algorithm for ankle OA. Several papers have been published concerning the cause of ankle OA and the possible conservative and operative treatment strategies. The conservative section mainly sums up the possibilities, however no algorithm is suggested (<a href="./references#CD010643-bbs2-0029" title="DemetriadesL , StraussE , GallinaJ . Osteoarthritis of the ankle. Clinical Orthopaedics and Related Research1998;349:28‐42. ">Demetriades 1998</a>; <a href="./references#CD010643-bbs2-0042" title="KatcherianDA . Treatment of ankle arthrosis. Clinical Orthopaedics and Related Research1998;349:48‐57. ">Katcherian 1998</a>; <a href="./references#CD010643-bbs2-0047" title="MartinRL , StewartGW , ContiSF . Posttraumatic ankle arthritis: an update on conservative and surgical management. Journal of Orthopaedic and Sports Physical Therapy2007;37(5):253‐9. ">Martin 2007</a>; <a href="./references#CD010643-bbs2-0058" title="RaoS , EllisSJ , DelandJT , HillstromH . Nonmedicinal therapy in the management of ankle arthritis. Current Opinion in Rheumatology2010;22(2):223‐8. ">Rao 2010</a>; <a href="./references#CD010643-bbs2-0071" title="ThomasRH , DanielsTR . Ankle arthritis. Journal of Bone and Joint Surgery, American Volume2003;85(5):923‐36. ">Thomas 2003</a>). We conducted this review to find evidence for the benefits and harms of non‐pharmacological and pharmacological treatment of ankle OA in general or by stage of the disease. We will try to provide a synthesis of the evidence as a base for future treatment guidelines. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010643-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-sec-0021">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-sec-0091">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010643-sec-0021"></div> <p>To assess the benefits and harms of any conservative treatment for ankle OA in adults in order to provide a synthesis of the evidence as a base for future treatment guidelines. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010643-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-sec-0022">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-sec-0092">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010643-sec-0022"></div> <section id="CD010643-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010643-sec-0024"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) and controlled clinical trials (CCTs) were included in this review. </p> </section> <section id="CD010643-sec-0025"> <h4 class="title">Types of participants</h4> <p>Adults with the diagnosis of symptomatic ankle osteoarthritis (OA) (primary or secondary) were included in this review. The diagnosis was based on well‐described clinical criteria e.g. the American College of Rheumatology (ACR) criteria (<a href="./references#CD010643-bbs2-0038" title="HochbergMC , AltmanRD , AprilKT , BenkhaltiM , GuyattG , McGowanJ , et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care &amp; Research2012;64(4):465‐74. ">Hochberg 2012</a>), or based on a previously taken X‐ray, which was classified using either the Kellgren Lawrence or the Van Dijk scale (<a href="./references#CD010643-bbs2-0036" title="HaradaY , TokudaO , FukudaK , ShiraishiG , MotomuraT , KimuraM , et al. Relationship between cartilage volume using MRI and Kellgren‐Lawrence radiographic score in knee osteoarthritis with and without meniscal tears. American Journal of Roentgenology2011;196(3):W298‐304. ">Harada 2011</a>; <a href="./references#CD010643-bbs2-0075" title="vanDijkCN , TolJL , VerheyenCC . A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. American Journal of Sports Medicine1997;25(6):737‐45. ">van Dijk 1997</a>). </p> </section> <section id="CD010643-sec-0026"> <h4 class="title">Types of interventions</h4> <p>Trials investigating any non‐surgical intervention were eligible.</p> <p>Trials investigating the following interventions were included:</p> <p> <ul id="CD010643-list-0001"> <li> <p>pharmacologic therapy — analgesics: acetaminophen, opioid analgesics like codeine, oxycodone or tramadol; NSAIDs like ibuprofen or celecoxib, intra‐articular glucocorticoids, intra‐articular hyaluronan, glucosamine and chondroitin; </p> </li> <li> <p>non‐pharmacologic therapy such as weight loss, rest, physical therapy and orthoses; braces, taping, insoles, exercise (strengthening, mobility, endurance and joint stability), manual therapy, diet, self management, psychosocial interventions (<a href="./references#CD010643-bbs2-0041" title="KalunianKC . Nonpharmacologic therapy of osteoarthritis. In: TugwellP , RomainPL editor(s). UpToDate. Waltham, MA (USA): UpToDate, 2012. ">Kalunian 2012</a>). </p> </li> </ul> </p> <p>Other methods including traditional medicine (e.g. herbs, acupuncture) and naturopathies were excluded. </p> <p>We tried to identify two special types of RCTs or CCTs:</p> <p> <ul id="CD010643-list-0002"> <li> <p>RCTs or CCTs that compared a treatment/therapy alone to placebo; and</p> </li> <li> <p>RCTs or CCTs that compared one treatment to the other.</p> </li> </ul> </p> </section> <section id="CD010643-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD010643-sec-0028"> <h5 class="title">Benefits</h5> <p> <ul id="CD010643-list-0003"> <li> <p>Pain with a hierarchy of seven levels (<a href="./references#CD010643-bbs2-0034" title="GhogomuEAT , MaxwellLJ , BuchbinderR , RaderT , PardoJ , et al. the Editorial Board of the Cochrane Musculoskeletal Group. Updated method guidelines for Cochrane Musculoskeletal Group Systematic Reviews and Metaanalyses. The Journal of Rheumatology2014;41(2):194‐205. [DOI: 10.3899/jrheum.121306] ">Ghogomu 2014</a>): </p> </li> </ul> <ul class="plain" id="CD010643-list-0004"> <li> <ul id="CD010643-list-0005"> <li> <p>pain of the affected joint;</p> </li> <li> <p>pain on walking;</p> </li> <li> <p>pain on activities other than walking;</p> </li> <li> <p>rest pain or pain during the night;</p> </li> <li> <p>other algofunctional scale (e.g. AOS pain or AOS total, <a href="./references#CD010643-bbs2-0031" title="DomsicRT , SaltzmanCL . Ankle osteoarthritis scale. Foot &amp; Ankle International1998;19(7):466‐71. ">Domsic 1998</a>); </p> </li> <li> <p>patient's global assessment;</p> </li> <li> <p>physician's global assessment.</p> </li> </ul> </li> </ul> </p> <p>When more than one was reported, the highest on the list was taken.</p> <p> <ul id="CD010643-list-0006"> <li> <p>Physical function with a hierarchy of eight levels (<a href="./references#CD010643-bbs2-0034" title="GhogomuEAT , MaxwellLJ , BuchbinderR , RaderT , PardoJ , et al. the Editorial Board of the Cochrane Musculoskeletal Group. Updated method guidelines for Cochrane Musculoskeletal Group Systematic Reviews and Metaanalyses. The Journal of Rheumatology2014;41(2):194‐205. [DOI: 10.3899/jrheum.121306] ">Ghogomu 2014</a>): </p> </li> </ul> <ul class="plain" id="CD010643-list-0007"> <li> <ul id="CD010643-list-0008"> <li> <p>global disability score;</p> </li> <li> <p>walking disability;</p> </li> <li> <p>disability other than walking;</p> </li> <li> <p>American Orthopedic Foot and Ankle Society score (AOFAS score, <a href="./references#CD010643-bbs2-0045" title="KitaokaHB , AlexanderIJ , AdelaarRS , NunleyJA , MyersonMS , SandersM . Clinical rating systems for the ankle‐hindfoot, midfoot, hallux, and lesser toes. Foot &amp; Ankle International1994;15(7):349‐53. ">Kitaoka 1994</a>); </p> </li> <li> <p>Foot and Ankle Outcome Score (FAOS, <a href="./references#CD010643-bbs2-0061" title="RoosEM , BrandssonS , KarlssonJ . Validation of the foot and ankle outcome score for ankle ligament reconstruction. Foot &amp; Ankle International2001;22(10):788‐94. ">Roos 2001</a>); </p> </li> <li> <p>Foot Function Index (FFI, <a href="./references#CD010643-bbs2-0024" title="Budiman‐MakE , ConradKJ , RoachKE . The Foot Function Index: a measure of foot pain and disability. Journal of Clinical Epidemiology1991;44(6):561‐70. [DOI: 10.1016/0895‐4356(91)90220‐4] ">Budiman‐Mak 1991</a>) ; </p> </li> <li> <p>Function (Range of Motion (ROM));</p> </li> <li> <p>other algofunctional scale (e.g. AOS disability or AOS total, <a href="./references#CD010643-bbs2-0031" title="DomsicRT , SaltzmanCL . Ankle osteoarthritis scale. Foot &amp; Ankle International1998;19(7):466‐71. ">Domsic 1998</a>). </p> </li> </ul> </li> </ul> </p> <p>When more than one was reported the highest on the list was taken.</p> <p> <ul id="CD010643-list-0009"> <li> <p>Radiographic joint structure changes according to the given hierarchy:</p> <ul id="CD010643-list-0010"> <li> <p>Kellgren Lawrence score (<a href="./references#CD010643-bbs2-0036" title="HaradaY , TokudaO , FukudaK , ShiraishiG , MotomuraT , KimuraM , et al. Relationship between cartilage volume using MRI and Kellgren‐Lawrence radiographic score in knee osteoarthritis with and without meniscal tears. American Journal of Roentgenology2011;196(3):W298‐304. ">Harada 2011</a>); </p> </li> <li> <p>van Dijk score (<a href="./references#CD010643-bbs2-0075" title="vanDijkCN , TolJL , VerheyenCC . A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. American Journal of Sports Medicine1997;25(6):737‐45. ">van Dijk 1997</a>). </p> </li> </ul> </li> <li> <p>Quality of Life:</p> </li> </ul> <ul class="plain" id="CD010643-list-0011"> <li> <ul id="CD010643-list-0012"> <li> <p>Short Form‐36 (SF‐36,<a href="./references#CD010643-bbs2-0076" title="WareJEJr , SherbourneCD . The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Medical Care1992;30(6):473‐83. ">Ware 1992</a>) </p> </li> <li> <p>EuroQoL‐5 Dimensions (EQ‐5D, <a href="./references#CD010643-bbs2-0066" title="SalénBA , SpangfortEV , NygrenAL , NordemarR . The Disability Rating Index: an instrument for the assessment of disability in clinical settings. Journal of Clinical Epidemiology1994;47(12):1423‐35. ">Salén 1994</a>). </p> </li> </ul> </li> </ul> </p> </section> <section id="CD010643-sec-0029"> <h5 class="title">Harms</h5> <p> <ul id="CD010643-list-0013"> <li> <p>Participants experiencing any serious adverse events (SAEs); a serious adverse event is defined as any adverse event, irrespective of a possible relationship to the administered treatment which leads to e.g. death, a life‐threatening event or requires hospitalisation. </p> </li> </ul> <ul id="CD010643-list-0014"> <li> <p>Number of participants experiencing any adverse event (AE); an adverse event is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product, which does not necessarily have a causal relationship with the treatment. </p> </li> </ul> <ul id="CD010643-list-0015"> <li> <p>Participants who withdraw because of an adverse event or any other reason</p> </li> </ul> </p> <p>If pain or function outcomes were reported at several time‐points, the end of treatment was taken as primary time‐point for pharmacologic treatment such as acetaminophen, opioids or NSAIDs, with the three‐months interval as an additional time‐point. </p> <p>In case of hyaluronan, glucocorticoids, glucosamine and chondroitine and nonpharmacologic therapy, six months was considered as primary time‐point and the three‐month interval as an additional time‐point. </p> </section> </section> </section> <section id="CD010643-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010643-sec-0031"> <h4 class="title">Electronic searches</h4> <p>A sensitive search strategy was designed to retrieve trials from electronic bibliographic databases, not limited to any intervention. The search strategy was devised for the Ovid MEDLINE interface The sensitivity maximizing filter for retrieving RCTs from MEDLINE and EMBASE was used as recommended in the <i>Cochrane Handbook for for Systematic Reviews of Interventions</i> (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>).<br/> No language restriction was applied.<br/> <br/> 11 to 18 September 2014, we searched the following electronic databases, unrestricted by date (from database inception) or language: </p> <p> <ul id="CD010643-list-0016"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library Issue 9, 2014) (<a href="./appendices#CD010643-sec-0070">Appendix 1</a>); </p> </li> <li> <p>MEDLINE (Ovid) 1946 to present (<a href="./appendices#CD010643-sec-0071">Appendix 2</a>); </p> </li> <li> <p>EMBASE (Ovid) 1947 to present (<a href="./appendices#CD010643-sec-0072">Appendix 3</a>); </p> </li> <li> <p>PsycINFO (American Psychological Association) 1806 to present (<a href="./appendices#CD010643-sec-0073">Appendix 4</a>); </p> </li> <li> <p>CINAHL (Cumalitive Index to Nursing and Allied Health Literature) (EBSCO)1985 to present (<a href="./appendices#CD010643-sec-0074">Appendix 5</a>); </p> </li> <li> <p>PEDro (Physiotherapy Evidence Database) (all years (<a href="./appendices#CD010643-sec-0075">Appendix 6</a>)); </p> </li> <li> <p>AMED (Allied and Alternative Medicine) (Ovid) 1985 to present (<a href="./appendices#CD010643-sec-0076">Appendix 7</a>). </p> </li> </ul> </p> </section> <section id="CD010643-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We searched the following clinical trial registries to identify ongoing trials:</p> <p> <ul id="CD010643-list-0017"> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>); </p> </li> <li> <p>Current Controlled Trials (<a href="http://www.controlled-trials.com/" target="_blank">http://www.controlled‐trials.com/</a>); </p> </li> <li> <p>The Dutch Register (<a href="http://www.trialregister.nl/trialreg/index.asp" target="_blank">http://www.trialregister.nl/trialreg/index.asp</a>). </p> </li> </ul> </p> <p>We also screened reference lists in retrieved review articles and trials to identify potentially relevant studies. </p> </section> </section> <section id="CD010643-sec-0033"> <h3 class="title" id="CD010643-sec-0033">Data collection and analysis</h3> <section id="CD010643-sec-0034"> <h4 class="title">Selection of studies</h4> <p>Two authors (AW, CH) independently screened records identified from database searches for possible inclusion. Full‐text articles were retrieved for further assessment when the initial information appeared to align with the review criteria. Trials not fulfilling the outlined selection criteria were excluded. Reasons for exclusion were documented. A third author (GK) moderated any disagreement. </p> </section> <section id="CD010643-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two authors (AW, GK) completed data extraction of the included studies and recorded this on a data extraction form. Disagreements were resolved by discussion. </p> <p>We collected data on study design characteristics, descriptive characteristics of the participants, interventions, outcome measures, and length of follow‐up. Trialists were contacted for clarification when necessary. </p> <p>The data extraction included the following:</p> <p> <ul id="CD010643-list-0018"> <li> <p>Generic publication characteristics:</p> </li> </ul> <ul class="plain" id="CD010643-list-0019"> <li> <ul id="CD010643-list-0020"> <li> <p>type of publication;</p> </li> <li> <p>title;</p> </li> <li> <p>authors;</p> </li> <li> <p>year of publication.</p> </li> </ul> </li> </ul> <ul id="CD010643-list-0021"> <li> <p>Research design:</p> </li> </ul> <ul class="plain" id="CD010643-list-0022"> <li> <ul id="CD010643-list-0023"> <li> <p>randomised controlled study/controlled clinical trial;</p> </li> <li> <p>blinding of outcome assessors;</p> </li> <li> <p>allocation concealment.</p> </li> </ul> </li> </ul> <ul id="CD010643-list-0024"> <li> <p>Descriptive characteristics of participants:</p> <ul id="CD010643-list-0025"> <li> <p>number of participants;</p> </li> <li> <p>age;</p> </li> <li> <p>sex;</p> </li> <li> <p>duration of ankle OA;</p> </li> <li> <p>grade of ankle OA;</p> </li> <li> <p>baseline measures;</p> </li> <li> <p>diagnoses; inclusion and exclusion criteria;</p> </li> <li> <p>if applicable, randomisation outcomes such as numbers allocated to each group at baseline, withdrawals, intention‐to‐treat numbers, and losses to follow‐up. </p> </li> </ul> </li> </ul> <ul id="CD010643-list-0026"> <li> <p>Intervention characteristics:</p> </li> </ul> <ul class="plain" id="CD010643-list-0027"> <li> <ul id="CD010643-list-0028"> <li> <p>non‐surgical intervention: analgesics — acetaminophen, opioid analgesics like codeine, oxycodone or tramadol, NSAIDs such as ibuprofen or celecoxib, intra‐articular glucocorticoids, intra‐articular hyaluronan, glucosamine and chondroitin; </p> </li> <li> <p>non‐pharmacologic therapy: weight loss, rest, physical therapy and orthoses: braces, taping, insoles, exercise (strengthening, mobility, endurance and joint stability), manual therapy, diet, self management, psychosocial interventions; </p> </li> <li> <p>comparative intervention;</p> </li> <li> <p>duration of the intervention (duration (weeks/months) and frequency);</p> </li> <li> <p>follow‐up.</p> </li> </ul> </li> </ul> <ul id="CD010643-list-0029"> <li> <p>Outcomes (benefits and harms):</p> </li> </ul> <ul class="plain" id="CD010643-list-0030"> <li> <ul id="CD010643-list-0031"> <li> <p>pain;</p> </li> <li> <p>safety;</p> </li> <li> <p>quality of life;</p> </li> <li> <p>physical function.</p> </li> </ul> </li> </ul> </p> <p>Disagreements in data extraction were resolved via discussion and further scrutiny of the original data. </p> </section> <section id="CD010643-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The Cochrane's tool for assessing risk of bias was used in the selected studies (<a href="http://archie.cochrane.org/sections/documents/view?version=z1304252110288817266337736248823%26format=REVMAN#REF-Higgins-2011" target="_blank">Higgins 2011</a>). Two authors (AW, GK) independently assessed generation of allocation sequence, allocation concealment, blinding, incomplete outcome data, selective outcome reporting (reporting bias), and other sources of bias (<i>baseline imbalance</i> in factors which are strongly related to outcome measures e.g. grade of ankle OA; <i>intervention characteristics</i> e.g. dosage of medication, frequency of therapy). </p> <p>Bias was judged as 'high risk' of bias, 'low risk' of bias, or 'unclear risk' of bias. We resolved disagreements by consensus or discussion with a third author (CH). </p> </section> <section id="CD010643-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>Intervention efficacy and safety were assessed by presenting the mean differences (MDs). When data could be pooled to perform a meta‐analysis, standardised mean differences (SMDs) were used when the same outcome was assessed but different scales were used to express this outcome. A 95% confidence interval (CI) was used for continuous outcomes; and risk ratio (RR) and 95% CI for dichotomous outcomes. A Peto odds ratio was used for rare events. </p> </section> <section id="CD010643-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant. If RCTs or CCTs were identified that treated both ankles, and the number of ankles was used as the denominator in the analysis without adjustment for the non‐independence between ankles (and thus a potential for unit of analysis error might occur), we attempted to re‐analyse such studies by calculating sample sizes where possible, according to the methods outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If it was stated in the article that more than 10% of the patients suffered from general OA, the treatment effect of any treatment for ankle OA would be very difficult to interpret and therefore these studies were excluded. </p> </section> <section id="CD010643-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Where we could not directly extract data the trialists were contacted, or missing data was imputed with replacement values, and treated as if they were observed (last observation carried forward) (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If data was imputed, we noted so in the table 'Characteristics of included studies'. </p> </section> <section id="CD010643-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We tested heterogeneity of the data using the Chi² with a P value less than 0.10 indicating significant heterogeneity. The I² statistic was assessed to quantify inconsistency across the results (I² = [Q df / Q] x 100%; where Q is the Chi² statistic and df is the degrees of freedom) (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). A value greater than 50% indicated substantial heterogeneity. Beside this procedure, we also performed a visual assessment of forest plots to assess heterogeneity (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD010643-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>We investigated selective outcome reporting bias by comparing the study outcomes with those routinely presented for similar studies and also by comparing the Methods section of trial reports with the results reported. </p> </section> <section id="CD010643-sec-0042"> <h4 class="title">Data synthesis</h4> <p>We pooled results of comparable groups of trials. Initially the fixed‐effect model and 95% CIs was used. A fixed‐effect meta‐analysis provided a result that may be viewed as a 'typical intervention effect' from the studies included in the analysis. A confidence interval for a fixed‐effect meta‐analysis was calculated: in order to do so the assumption was made that the true effect of intervention (in both magnitude and direction) was the same value in every study (that is, fixed across studies). This assumption implied that the observed differences among study results were due solely to the play of chance, i.e. that there was no statistical heterogeneity (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The random‐effects model was considered, especially where there was unexplained heterogeneity (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The Cochrane's statistical software for data synthesis, <a href="./references#CD010643-bbs2-0059" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013. ">Review Manager 5</a>, was used. </p> </section> <section id="CD010643-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Due to the lack of data a subgroup analysis was not performed. If sufficient data had been present, an analysis between the benefits and harms of conservative treatments for each grade of OA of the Kellgren Lawrence score (grade 1, 2, 3) or the van Dijk score (grade 1 or 2) would have been performed. </p> </section> <section id="CD010643-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the low number of eligible studies no sensitivity analysis was performed.</p> <section id="CD010643-sec-0045"> <h5 class="title">Summary of findings table</h5> <p>The main findings of the study are presented in a 'Summary of findings' table, produced using GRADEpro software (<a href="./references#CD010643-bbs2-0035" title="Jan Brozek, Andrew Oxman, Holger Schünemann. GRADEprofiler (GRADEpro). Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Schünemann, 2008. ">GRADEprofiler 2008</a>). This table provides key information concerning the quality of the evidence, the magnitude of effect of the interventions examined, and the sum of available data on the main outcomes. The table includes an overall grading of the evidence related to each of the main outcomes using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, as indicated in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (study limitation, indirectness, inconsistency, imprecision, publication bias) (<a href="./references#CD010643-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). A 'Summary of findings' is made when sufficient data can be pooled (data synthesis) or for any comparison that is deemed clinically important. The important outcomes that were included in the 'Summary of findings' tables are: </p> <p> <ol id="CD010643-list-0032"> <li> <p>pain;</p> </li> <li> <p>physical function;</p> </li> <li> <p>combined score of pain and physical function (AOS total)</p> </li> <li> <p>radiographic joint structures changes;</p> </li> <li> <p>quality of life;</p> </li> <li> <p>number of participants experiencing any serious adverse events;</p> </li> <li> <p>number of participants experiencing any adverse event;</p> </li> <li> <p>participants who withdraw because of an adverse event or any other reason.</p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010643-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010643-sec-0046"></div> <section id="CD010643-sec-0047"> <h3 class="title">Description of studies</h3> <section id="CD010643-sec-0048"> <h4 class="title">Results of the search</h4> <p>After performing the first search up to 11 September 2014, 2945 references were retrieved; after de‐duplication this resulted in 2257 citations (1126 MEDLINE, 656 EMBASE, 98 CENTRAL, 50 CINAHL, 138 PsycINFO, 14 PEDro, 175 AMED). </p> <p>No additional studies or ongoing studies were found searching the trial registers.</p> <p>After screening the titles and abstracts of these references 14 full‐text articles were selected; after de‐duplication 13 remained. Seven were excluded and six were included. </p> <p>See the study flowchart for further details (<a href="#CD010643-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010643-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010643-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD010643-sec-0049"> <h4 class="title">Included studies</h4> <p>The six included studies are listed in the 'Characteristics of included studies' table. Years of publication ranged from 2006 to 2014. </p> <p>All studies are blinded randomised controlled trials (RCTs), three are double‐blinded RCTs (<a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>). These three studies compared the intra‐articular injection of hyaluronic acid (HA) to placebo. Authors of these studies were contacted by email to get the exact results of the scores they used in their trials. <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> were not able to provide us with these data. <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> did send his original database. Two compared two different treatments: HA injection compared to exercise therapy (<a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a>); or HA combined with exercise therapy versus injection of Intra‐articular botulinum toxin A (<a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a>). <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> compared the efficacy and safety of four different doses of HA. A total of 240 participants were involved. All were clinically diagnosed with ankle osteoarthritis (OA) which was confirmed radiographically. All participants were in generally good health. The Kellgren Lawrence score as well as the van Dijk score was used as classification for the radiographic presence of OA (<a href="./references#CD010643-bbs2-0043" title="KellgrenJH , LawrenceJS . Radiological Assessment of Osteo‐Arthrosis. Annals of the Rheumatic Diseases1957;16(4):494‐502. [DOI: 10.1136/ard.16.4.494] ">Kellgren 1957</a>; <a href="./references#CD010643-bbs2-0075" title="vanDijkCN , TolJL , VerheyenCC . A prospective study of prognostic factors concerning the outcome of arthroscopic surgery for anterior ankle impingement. American Journal of Sports Medicine1997;25(6):737‐45. ">van Dijk 1997</a>). All studies except <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> investigated people with unilateral ankle pain. The study population sizes at randomisation varied: 17 (<a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>), 75 (<a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a>), 28 (<a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>), 30 (<a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a>), 64 (<a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>), 26 (<a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a>). Participants were 18 years or older. <a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> included participants between the age of 20 and 85 years and <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> participants were 50 years or older. </p> <p>Follow‐up in all studies ranged from 3 to 12 months. Either the Ankle Osteoarthritis Scale (AOS, <a href="./references#CD010643-bbs2-0031" title="DomsicRT , SaltzmanCL . Ankle osteoarthritis scale. Foot &amp; Ankle International1998;19(7):466‐71. ">Domsic 1998</a>) or American Orthopedic Foot and Ankle Society score (AOFAS, <a href="./references#CD010643-bbs2-0045" title="KitaokaHB , AlexanderIJ , AdelaarRS , NunleyJA , MyersonMS , SandersM . Clinical rating systems for the ankle‐hindfoot, midfoot, hallux, and lesser toes. Foot &amp; Ankle International1994;15(7):349‐53. ">Kitaoka 1994</a>) or the Visual Analogue Scale (VAS, <a href="./references#CD010643-bbs2-0053" title="OhnhausEE , AdlerR . Methodological problems in the measurement of pain: a comparison between the verbal rating scale and the visual analogue scale. Pain1975;1(4):379‐84. ">Ohnhaus 1975</a>) were used as primary outcome measure. Different types of HA, dosage or dosing schedules were used in each trial. <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> used 5 weekly injections of 1 ml hyaluronic acid (Hyalgan®) compared to saline. <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> used five weekly injections of 2 ml of hyaluronic acid (Hyalgan®) compared to 5 injections of 2 ml of saline. <a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> used a single injection of 2 ml hyaluronic acid (Hyalgan®). <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> used three weekly injections of 2.5 ml hyaluronic acid (Adant®). <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> used a single 2 ml injection of hyaluronic acid (Supartz®) compared to saline. <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> investigated four different doses; single injections of 1, 2, 3 ml, and 3 weekly injections of 1 ml (3 x 1 ml) of hyaluronic acid (Orthovisc®). </p> </section> <section id="CD010643-sec-0050"> <h4 class="title">Excluded studies</h4> <p>A total of seven studies were excluded because they were not randomised controlled trials (<a href="./references#CD010643-bbs2-0007" title="HuangYC , HarbstK , KotajarviB , HansenD , KoffMF , KitaokaHB , et al. Effects of ankle‐foot orthoses on ankle and foot kinematics in patient with ankle osteoarthritis. Archives of Physical Medicine and Rehabilitation2006;87(0003‐9993 (Print), 0003‐9993 (Linking), 5):710‐6. ">Huang 2006</a>; <a href="./references#CD010643-bbs2-0008" title="LucianiD , CadossiM , TeseiF , ChiarelloE , GianniniS . Viscosupplementation for grade II osteoarthritis of the ankle: a prospective study at 18 months' follow‐up. La Chirurgia degli Organi di Movimento2008;92(1973‐2538 (Electronic), 0009‐4749 (Linking), 3):155‐60. ">Luciani 2008</a>; <a href="./references#CD010643-bbs2-0009" title="Mei‐DanO , KishB , ShabatS , MasarawaS , ShterenA , MannG , et al. Treatment of osteoarthritis of the ankle by intra‐articular injections of hyaluronic acid: a prospective study. Journal of the American Podiatric Medical Association2010;100(1930‐8264 (Electronic), 1930‐8264 (Linking), 2):93‐100. ">Mei‐Dan 2010</a>; <a href="./references#CD010643-bbs2-0010" title="SarkinTL . Indications for intra‐articular steroid in osteoarthritis of the ankle and big toe joints. South African Medical Journal1974;48(0256‐9574 (Print), 0256‐9574 (Linking), 49):2067‐8. ">Sarkin 1974</a>; <a href="./references#CD010643-bbs2-0011" title="SunSF , ChouYJ , HsuCW , HwangCW , HsuPT , WangJL , et al. Efficacy of intra‐articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthritis and Cartilage2006;14:867‐74. ">Sun 2006</a>; <a href="./references#CD010643-bbs2-0012" title="SunSF , HsuCW , SunHP , ChouYJ , LiHJ , WangJL . The effect of three weekly intra‐articular injections of hyaluronate on pain, function, and balance in patients with unilateral ankle arthritis. The Journal of Bone and Joint Surgery, American Volume2011;93(1535‐1386 (Electronic), 18):1720‐6. ">Sun 2011</a>; <a href="./references#CD010643-bbs2-0013" title="WitteveenAG , GianniniS , GuidoG , JeroschJ , LohrerH , VanniniF , et al. A prospective multi‐centre, open study of the safety and efficacy of hylan G‐F 20 (Synvisc) in patients with symptomatic ankle (talo‐crural) osteoarthritis. Foot and Ankle Surgery2008;14(3):145‐52. ">Witteveen 2008</a>). See the table of <a href="./references#CD010643-sec-0085" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD010643-sec-0051"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD010643-fig-0002">Figure 2</a>; <a href="#CD010643-fig-0003">Figure 3</a> </p> <div class="figure" id="CD010643-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010643-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD010643-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010643-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD010643-sec-0052"> <h4 class="title">Allocation</h4> <p>Generally most randomised controlled trials (4/6) described their randomisation process adequately (low risk of bias). <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> mentioned a randomised component; however the process was not described so it was unclear which process was used to conceal allocation. </p> </section> <section id="CD010643-sec-0053"> <h4 class="title">Blinding</h4> <p>Three studies were classified as having a low risk for performance bias and detection bias (<a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>). <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> was classified as unclear for performance bias and detection bias: it is most likely, since the participants were not blinded, that they informed the physical therapist about the treatment they got. Since the outcome was partly participant‐reported, detection bias was considered unclear because these results can be affected by the fact the participant might have a preference for either therapy. For <a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> we assessed a high risk for performance bias, since the participants could not be blinded so most likely this information went to the therapist, which could influence the outcome; the secondary outcomes could be biased by this information so detection bias was considered to be high as well. <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> was classified as high risk for performance and detection bias: participants were not blinded, and it is likely that they judged the fact that they got more injections as better, and therefore performed better, which might have resulted in a better outcome. </p> </section> <section id="CD010643-sec-0054"> <h4 class="title">Incomplete outcome data</h4> <p>All studies but one were classified as low risk for incomplete data. <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> described three participants that did not complete the study. However an intention‐to‐treat analysis (ITT) was not described (unclear risk). </p> </section> <section id="CD010643-sec-0055"> <h4 class="title">Selective reporting</h4> <p>For <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> it was unclear if there was reporting bias: there was a follow‐up of only three months, which can favour placebo and therefore affect the results. </p> </section> <section id="CD010643-sec-0056"> <h4 class="title">Other potential sources of bias</h4> <p><a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> was classified as an unclear risk because there was a difference in participant demographics: a significant difference between the mean age of participants in each group was noted as well as a difference between baseline AOS total scores and Western Ontario and McMasters Universities (WOMAC) pain scores (<a href="./references#CD010643-bbs2-0018" title="BellamyN , BuchananWW , GoldsmithCH , CampbellJ , StittLW . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology1988;15(12):1833‐40. ">Bellamy 1988</a>). <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> was also classified as an unclear risk for other bias since the placebo and treatment group were of unequal sizes, 25 compared to 39. <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> was also classified as having an unclear risk because the group that was assigned to exercise therapy had a significantly higher AOFAS score at baseline. <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> was classified unclear since the group that received the 2 ml injections performed unexplainably badly. </p> </section> </section> <section id="CD010643-sec-0057"> <h3 class="title" id="CD010643-sec-0057">Effects of interventions</h3> <p>See: <a href="./full#CD010643-tbl-0001"><b>Summary of findings for the main comparison</b> Hyaluronic acid for osteoarthritis of the ankle</a> </p> <p><b>Primary analysis: intra‐articular injection of hyaluronic acid compared to placebo (3 studies):</b> </p> <p>Three studies compared the intra articular injection of hyaluronic acid in the ankle to placebo (saline) (<a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>). <a href="./full#CD010643-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p><b>BENEFITS</b> <b>:</b> </p> <p><i><b>Pain</b> </i><a href="./references#CD010643-fig-0004" title="">Analysis 1.1</a>, </p> <p>For the outcome 'pain', the AOS pain (at three months) and the total AOS score (at six months) were used to compare the studies. The total AOS was used to make possible a comparison of the two studies used in the meta‐analysis for the primary outcome at six months. Upon contacting the authors no additional information could be provided to perform a sub‐pooled analysis for AOS pain at six months. </p> <p>In the meta‐analysis (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>; 45 participants) compared to control at six months (primary outcome) the AOS total score was 12.53 points lower mean difference (MD) in favour for HA (95% confidence interval (CI) −23.84 to −1.22; <a href="./references#CD010643-fig-0004" title="">Analysis 1.1</a>). We downgraded the quality of evidence from high to low due to the limitation in study design (unclear risk of bias) and imprecision of result (low number of participants). At three months (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; 92 participants) compared to control the total AOS score was 2.26 lower points lower (MD) (95% CI −11.23 to 6.72 <a href="./references#CD010643-fig-0005" title="">Analysis 1.2</a>,) We downgraded the quality of evidence from high to very low due to a serious imprecision of results (low number of participants and studies are on opposite sides of null effect) and limitation in study design (unclear bias). At three months (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>, <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; 92 participants) compared to control the AOS sub score pain was 1.83 points lower (MD) (95% CI −11.33 to 7.68; <a href="./references#CD010643-fig-0006" title="">Analysis 1.3</a>,). We downgraded the quality of evidence from high to very low due to serious imprecision of results (low number of participants and studies are on opposite sides of null effect) and limitation in study design (unclear bias). </p> <p><i><b>Physical function</b> </i><a href="./references#CD010643-fig-0004" title="">Analysis 1.1</a>, </p> <p>To compare physical function between studies, the AOS disability score (at three months) and the AOS total score (at six months) was used. The total AOS was used to make possible a comparison of the two studies used in the meta‐analysis for the primary outcome at six months. Upon contacting the authors no additional information could be provided to perform a sub analysis for AOS disability at six months. </p> <p>In the meta‐analysis at six months (primary outcome) (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>; 45 participants) compared to control the AOS total score was 12.53 points lower (MD) in favour of HA (95% CI −23.84 to −1.22; <a href="./references#CD010643-fig-0004" title="">Analysis 1.1</a>). We downgraded the quality of evidence from high to low due to the limitation in study design (unclear risk of bias) and imprecision of result (low number of participants). At three months (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; 92 participants) compared to control the total AOS score was 2.26 points lower (MD) (95% CI −11.23 to 6.72; <a href="./references#CD010643-fig-0005" title="">Analysis 1.2</a>). We downgraded the quality of evidence from high to very low due to serious imprecision of results (low number of participants and studies are on opposite sides of null effect) and limitation in study design (unclear bias). At three months (two studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; 92 participants) compared to control the AOS sub score disability was 0.13 points lower (MD) (95% CI −9.26 to 9.01; <a href="./references#CD010643-fig-0007" title="">Analysis 1.4</a>). We downgraded the quality of evidence from high to very low due to serious imprecision of results (low number of participants and studies are on opposite sides of null effect) and limitation in study design (unclear bias). </p> <p><i><b>Radiographic joint structure changes</b> </i> was not examined in either study. </p> <p><i><b>Quality of life</b> </i> as outcome was only described in two studies (<a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> and <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>); both used the Short‐Form 12 (SF12) (<a href="./references#CD010643-bbs2-0077" title="WareJJr , KosinskiM , KellerSD . A 12‐Item Short‐Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care1996;34(3):220‐33. ">Ware 1996</a>). </p> <p><a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>: SF12 demonstrated no significant difference in their paper between either group at six months, no exact scores were mentioned in the study results and could not be provided upon contacting the author. </p> <p><a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>: SF12 demonstrated a significant difference in their paper favouring hyaluronic acid at six months, no standard deviations were present in the result section of the study, upon contacting the author they could not be provided. </p> <p>Since the exact scores were not available, no meta‐analysis could be performed for this score. </p> <p><b>HARMS</b> <a href="./references#CD010643-fig-0008" title="">Analysis 1.5</a>; <a href="./references#CD010643-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD010643-fig-0010" title="">Analysis 1.7</a> </p> <p>A meta‐analysis (three studies: <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>, <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>, <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>; 109 participants) showed a similar amount of AEs in either group (Peto odds ratio (Peto OR) 2.34, 95% CI 0.45 to 12.11; <a href="./references#CD010643-fig-0009" title="">Analysis 1.6</a>). No SAEs were found and no participant withdrew due to an AE (<a href="./references#CD010643-fig-0008" title="">Analysis 1.5</a>; <a href="./references#CD010643-fig-0010" title="">Analysis 1.7</a>). </p> <p><i><b>Heterogeneity and sensitivity analysis:</b> </i> </p> <p>A substantial heterogeneity of 89% was found for <a href="./references#CD010643-fig-0005" title="">Analysis 1.2</a> . For <a href="./references#CD010643-fig-0006" title="">Analysis 1.3</a> 84%; and 89% for <a href="./references#CD010643-fig-0007" title="">Analysis 1.4</a>. Due to the fact that each analysis, except the harms analyses, only contained two studies no sensitivity analyses was done. </p> <p><b>Intra‐articular injection of hyaluronic acid compared to exercise therapy:</b> </p> <p><a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> described the comparison of injection HA to exercise therapy (<a href="./appendices#CD010643-sec-0077">Appendix 8</a>). </p> <p><b>BENEFITS</b> <b>:</b> </p> <p><i><b>Pain</b> </i> during activity (VAS 0 to 10) showed a decrease in pain (end point was at 12 months) (MD −0.70, 95% CI −2.54 to 1.14; <a href="./references#CD010643-fig-0011" title="">Analysis 2.1</a>). We downgraded the quality of evidence from high to low due to the unclear risk of bias and small sample size (imprecision of results and limitation of design). </p> <p><i><b>Physical function</b> </i> : At 12 months compared to exercise the AOFAS score was 13.10 points higher (MD) in favour of hyaluronic acid (95% CI 2.97 to 23.23 <a href="./references#CD010643-fig-0012" title="">Analysis 2.2</a>) on a scale of 0 to 100. We downgraded the quality of evidence from high to low due to the unclear risk of bias (limitation in study design) and small sample size (imprecision of result). At 12 months compared to exercise the walking distance was 0.30 points (MD) better in favour of exercise therapy at 12 months (95% CI −1.27 to 0.67; <a href="./references#CD010643-fig-0013" title="">Analysis 2.3</a>) We downgraded the quality of evidence from high to low due to the unclear risk of bias and small sample size. </p> <p><i><b>Radiographic joint structure changes</b> </i> was not measured. </p> <p><i><b>No quality of life</b> </i> score was measured. </p> <p><b>HARMS:</b> </p> <p>No AEs were found for either group.</p> <p><b>Intra‐articular injection of hyaluronic acid combined with exercise therapy compared to intra‐articular botulinum toxin A (BoNT‐A) injection:</b> </p> <p><a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> described the comparison of HA injection combined with exercise therapy to an intra‐articular injection of botulinum toxin A (<a href="./appendices#CD010643-sec-0078">Appendix 9</a>). </p> <p><b>BENEFITS:</b> </p> <p><i><b>Pain:</b> </i> At six months compared to botulinum toxin A the AOS pain score of the affected joint showed a decrease in pain (MD 0.10, 95% CI −0.42 to 0.62: <a href="./references#CD010643-fig-0014" title="">Analysis 3.1</a>). We downgraded the quality of evidence from high to low due to the high risk of bias and small sample size. </p> <p><i><b>Physical function</b> </i> : At six months compared to botulinum toxin A the AOS disability score showed a decrease in physical function (MD 0.20, 95% CI −0.34 to 0.74; <a href="./references#CD010643-fig-0015" title="">Analysis 3.2</a>). We downgraded the quality of evidence from high to low due to the high risk of bias and small sample size. </p> <p><i><b>Radiographic joint structure changes</b> </i> was not measured. </p> <p><i><b>No quality of life</b> </i> score was measured. </p> <p><b>HARMS:</b> </p> <p>In the HA group 2/37 (5.9%) AEs were found, in the BoNT‐A 2/38 (5.8%) (RR 1.03, 95% CI 0.15 to 6.91; <a href="./references#CD010643-fig-0016" title="">Analysis 3.3</a>). The AEs consisted of transient injection site reaction and were mild/moderately painful and resolved without treatment. </p> <p><b>Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint:<br/> Effects, safety and dose dependency:</b> </p> <p><a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> randomised trial; four different dosages of intra‐articular injections of HA were randomly allocated; 1 ml, 2 ml, 3 ml and 3 weekly injections of 1 ml were compared for efficacy. Primary endpoint of the study was 15 weeks (<a href="./appendices#CD010643-sec-0079">Appendix 10</a>). </p> <p><b>Benefits:</b> </p> <p><i><b>Pain (during walking (VAS):</b> </i> None of the VAS‐scores for ‘pain during walking activities’ decreased significantly at week 15. The 3 x 1 ml dose group performed best (P = 0.075).<br/> The VAS‐scores of the 1, 2, and 3 ml dose groups separately did not change significantly as compared to baseline scores at both secondary endpoints (week 7 and 27) (0.23 &lt; P &lt; 0.74). At week 7, a statistically significant median decrease of the VAS‐score of 29 mm was observed in the 3 x 1 ml dosage group (P = 0.046).<br/> The median change in decrease of pain at 27 weeks was best for 3 x 1 (−30), however this was not statistically significant (P = 0.25). We downgraded the quality of evidence from high to moderate due to small sample sizes (imprecision of results). </p> <p><i><b>Physical function:</b> </i> No physical function was measured. </p> <p><i><b>Radiographic joint structure changes</b> </i> was not measured. </p> <p><i><b>Quality of life:</b> </i> No quality of life was measured. </p> <p><b>Harms:</b> </p> <p>Adverse events: AEs happened the most in the 2 ml group (57%), other groups had an adverse event rate of 14% to 17%. The total number of AEs was 7 out of 26 participants (27%). These AEs consisted of increased pain and swelling of the ankle joint. They were mild or moderate in severity and resolved within 3 days. One participant experienced severe pain and swelling for a week. </p> <p>No serious adverse events were reported.</p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010643-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010643-sec-0058">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010643-sec-0100">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010643-sec-0058"></div> <section id="CD010643-sec-0059"> <h3 class="title" id="CD010643-sec-0059">Summary of main results</h3> <p>No other RCT concerning any other conservative treatment was identified except six RCT's, analysing the use of hyaluronic acid (HA) for ankle osteoarthritis (OA). </p> <p>A total of 240 participants diagnosed with ankle OA were included in this review. The primary analysis concerned three RCTs (109 participants) which compared HA to placebo (<a href="./full#CD010643-tbl-0001">summary of findings Table for the main comparison</a>). A meta‐analysis was performed to investigate the benefits and harms: HA showed a lower AOS total score than placebo at six months (primary outcome). The total AOS was used to make a comparison between studies possible, no exact sub‐scores (AOS pain or disability) for the outcome at six months could be provided upon contacting the authors. The difference in score was found to be promising; however it is not known if a mean difference of 12.53 points on a 100 point scale is clinically relevant. No minimal important clinical difference is known for this score. At three months a decrease (1.83 points) was found for the AOS sub‐score pain in favour of HA; however CI are wide and sample sizes are small, which make these results inconclusive. The AOS sub‐score for disability decreased 0.13 points at three months in favour of HA. Since CI were wide and sample sizes are small these results are difficult to interpret and inconclusive. </p> <p>Quality of life was difficult to judge due to the fact that the exact numbers were missing, <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> demonstrated a difference in favour of HA in his paper, <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> found similar results between both groups. </p> <p>There were a few adverse events (AEs); 5/63 (8%) in the HA group and 2/46 (4%) in the placebo group. The Peto odds ratio (Peto OR) to have an adverse event was 2.34 higher compared to the control group (95% CI 0.45 to 12.11). This evidence is inconclusive because of a wide CI and a small number of events. Evidence for this pooled analysis was graded as low due to limitation in study design (unclear risk of selection bias for two studies and unclear risk for attrition bias for one study); and imprecision of results based on a small population size (109 participants; the total sample size is lower than the calculated optimal information size of 400 participants for continuous outcomes). </p> <p><a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> compared HA and exercise therapy; a decrease in pain (VAS 0 to 10) of 0.7 points was found at 12 months. Since the CI crosses 0 and sample sizes are small (30 participants) these results are inconclusive. For physical function at 12 months the total AOFAS score (0 to 100) was 13.10 higher in favour of hyaluronic acid: this result is considered promising. These results were also graded as low due to limitation in study design; bias of blinding was unclear and other bias was unclear and imprecision of results due to a small population size (30). </p> <p><a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> described the comparison of hyaluronic acid injection combined with exercise therapy to an intra‐articular injection of botulinum toxin A. A decrease in pain and physical function were found in both groups. The decrease, however, is small: for pain it was 0.10 and for physical function 0.20 (on a scale of 0 to 100). Since the reduction in pain and physical function is so small, it is probably not clinically relevant. Also sample sizes (75 participants) are small and the CI crosses 0: the results are therefore considered inconclusive. The number of adverse events were comparable in both groups. This evidence was also graded as low due to limitation in study design; a high risk of bias for blinding of outcome and participants; and imprecision of results due to a small population size (75). </p> <p><a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> compared four different dosing schedules for intra‐articular injections of HA for efficacy and safety (26 participants). The best median decrease in pain on walking VAS (on a scale of 0 to 100) was shown for 3 x 1 ml at 27 weeks with a median decrease of 30. Physical function, radiographic changes and quality of life were not measured. The total number of AEs was 27%; most of them occurred in the 2 ml group (57%). No participants withdrew due to an AE and no SAEs were noted. This evidence was graded as low due to imprecision of results due to a small sample size of participants (26) and a limitation in study design — high risk of bias for blinding of outcome and participants. </p> </section> <section id="CD010643-sec-0060"> <h3 class="title" id="CD010643-sec-0060">Overall completeness and applicability of evidence</h3> <p>The objective of this review was to assess the benefits and harms of any conservative treatment of ankle OA. No randomised or clinical controlled trials were identified besides the six aforementioned RCTs. These trials all concerned the use of HA infiltrations for ankle OA. No trial (RCT/CCT or ongoing trials) were identified concerning any other conservative treatment. </p> <p>Three trials were pooled; HA was compared to placebo. Different dosage schedules were used between the studies. <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> used 5 weekly injections of 2 ml Hyalgan®, <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> used 5 weekly injections of 1 ml Hyalgan®, whereas <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> used a single injection of 2.5 ml of Supartz®. At this point it is unclear what dosage should be used for each type of hyaluronic acid injections. For instance it was found by <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> that 3 x 1 ml of Orthovisc® performed best for this type of HA. HA restores the rheologic properties of the joint, and is thought to protect the cartilage by improving the viscoelasticity (<a href="./references#CD010643-bbs2-0016" title="BalazsEA . Viscosupplementation: a new concept in the treatment of osteoarthritis. The Journal of Rheumatology. Supplement1993;39:3‐9. ">Balazs 1993</a>; <a href="./references#CD010643-bbs2-0019" title="BellamyN , CampbellJ , WelchV , GeeTL , BourneR , WellsGA . Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD005321.pub2] ">Bellamy 2006</a>). </p> <p>There is a remarkable difference in results between the primary outcome at six months (AOS total) and the individual scores (AOS pain and AOS disability) and the AOS total at the additional time point of three months. Since the results at three months are difficult to interpret due to a serious imprecision of results this needs further investigation. A possible explanation can be the fact that the placebo effect might wear off at three months, but at this point this is nothing more than speculation. It is not clear which grade of OA responds best to HA infiltrations; however grade 3 van Dijk or grade 4 Kellgren Lawrence are less likely to respond. The three trials included in the meta‐analysis all included grade 2, 3 and 4 of Kellgren Lawrence without making a subgroup analysis. </p> <p>HA in these studies is thought to improve pain and function; this is mainly the short‐term of effect. The long‐term effect, by improving the rheologic properties, is thought to slow down progression of the osteoarthritis of the joint; however none of these studies investigated this outcome. <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> investigated 3 weekly injections of 2.5 ml Adant® compared to 6 weeks of exercise therapy; these people suffered sometimes from bilateral ankle OA and knee pain as well. <a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> compared one injection of 2ml of Hyalgan® combined with 4 weeks of 3‐weekly sessions of physical therapy to one injection of Botulinum toxin A. Both injections are assumed to improve pain; why exercise therapy was added to hyaluronic acid remains unclear and seems unnecessary. All these differences between studies—the uncertainty about factors like dosage schedule, the ideal grade of ankle OA for this kind of treatment, and the lack of evidence for other types of conservative treatment—make it difficult to assess the applicability of evidence. At this point no valid recommendations can be made. </p> </section> <section id="CD010643-sec-0061"> <h3 class="title" id="CD010643-sec-0061">Quality of the evidence</h3> <p>Overall the quality of the evidence showed some serious limitations. There was a limitation in design and implementation and imprecision of the results for the meta‐analysis. Limitation in study design was based on the risk of bias which was judged to be at low risk or unclear for all the categories concerning the three studies used in the meta‐analysis. <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a> was marked unclear because this study showed no clear randomisation and allocation process and there was a baseline imbalance between both groups for age. <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a> was marked unclear for other bias because the study had an unequal size in number of participants between treatment and placebo group (39/25). The follow‐up of this study was limited to three months, it is possible that if the follow‐up had been longer the treatment group could have performed better due to the diminishing effect of placebo. <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a> was marked unclear because he had no description of the randomisation and allocation process. All three studies concerning the meta‐analysis included Kellgren Lawrence grade IV patients, severe arthritis is known not to respond well to hyaluronic acid treatment, this was also judged as an unclear bias. All these trials had a very low number of participants, the total number of participants used for the pooled analysis was 109, this total sample size is lower than the calculated optimal information size of 400 patients for continuous outcomes. This limitation and imprecision of results led to downgrading the evidence to low for the major outcomes. The limitation in study design and imprecision of results also led to a downgrade of two levels for the primary analysis; comparing HA to placebo, in the SOF table, resulting in a low quality as well. </p> <p><a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a> had a limitation of study design; an unclear risk of performance and detection bias because blinding was unclear for the participant and the evaluator could be biased since the participant was aware which treatment he underwent, other bias was marked unclear because some participants had bilateral involvement of ankle OA which make judgement of efficacy difficult and a small and an imprecision of results due to a small participant size (30), which led to downgrading the evidence to low for all outcomes. <a href="./references#CD010643-bbs2-0005" title="Shu‐FenSun , Chien‐WeiHsu , Huey‐ShyanLin , Yi‐JiunChou , Jun‐YangChen , Jue‐LongWang . Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial. Journal of Foot and Ankle Research2014;7(9):1‐9. ">Sun 2014</a> had a limitation study design due to a high risk bias due to the lack of blinding of participants and evaluators and also an imprecision of results due to a small sample size (75). This led to downgrading of the evidence to low for all outcomes. <a href="./references#CD010643-bbs2-0006" title="WitteveenAG , SiereveltIN , BlankevoortL , KerkhoffsGM , vanDijkCN . Intra‐articular sodium hyaluronate injections in the osteoarthritic ankle joint: effects, safety and dose dependency. Foot and Ankle Surgery2010;16(4):159‐63. ">Witteveen 2010</a> had a limitation in study design due to high risk in performance and detection bias, participants could not be blinded which possibly led to bias in participant‐reported outcome, there was also an imprecision of results due to a small sample size this led to downgrading the evidence to low for all outcomes. </p> <p>Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. No other reasons for downgrading the evidence were found for any of the included studies (indirectness of evidence, unexplained heterogeneity, high probability of publication bias). </p> </section> <section id="CD010643-sec-0062"> <h3 class="title" id="CD010643-sec-0062">Potential biases in the review process</h3> <p>To minimise the change of bias during the review process, the review was performed according to the published protocol. Due to the fact we did find a low number of eligible studies a sensitive search was added in order to include as much studies as possible and to minimise the chance of publication bias. A sensitive search strategy was designed to retrieve trials from electronic bibliographic databases, not limited to any intervention or language. Our search also included a search for ongoing and recently completed trials. However it is still possible that potentially relevant trials have been missed. In order to get additional data from retrieved trials, trialists were contacted, they were forthcoming, however no further data could be obtained. A meta‐analysis was conducted and data were pooled, it is possible that due to missing data, unclear biases in the pooled trials, pooling of small sample sizes and comparing trials that used different dosing schedules, data were compared that are not truly comparable, in this way potential bias might be introduced. </p> </section> <section id="CD010643-sec-0063"> <h3 class="title" id="CD010643-sec-0063">Agreements and disagreements with other studies or reviews</h3> <p>The number of studies and reviews concerning the use of hyaluronic acid for ankle osteoarthritis are very limited. Three reviews were identified (<a href="./references#CD010643-bbs2-0014" title="AbateM , SchiavoneC , SaliniV . Hyaluronic acid in ankle osteoarthritis: why evidence of efficacy is still lacking?. Clinical and Experimental Rheumatology2012 Mar‐Apr;30(2):277‐81. [PUBMED: 22338615] ">Abate 2012</a>; <a href="./references#CD010643-bbs2-0027" title="ChangKV , HsiaoMY , ChenWS , WangTG , ChienKL . Effectiveness of intra‐articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta‐analysis. Archives of Physical Medicine and Rehabilitation2013;94(5):951‐60. ">Chang 2013</a>; <a href="./references#CD010643-bbs2-0050" title="MiglioreA , GiovannangeliF , BizziE , MassafraU , AlimontiA , LaganàB , Diamanti PicchiantiA , GermanoV , GranataM , PiscitelliP . Viscosupplementation in the management of ankle osteoarthritis: a review. Archives of Orthopaedic and Trauma Surgery2011 Jan;31(1):139‐47. [DOI: 10.1007/s00402‐010‐1165‐5] ">Migliore 2011</a>). One randomised study was included in all these reviews and was not eligible in our review, since HA was administered arthroscopically after arthroscopic debridement (<a href="./references#CD010643-bbs2-0025" title="CarpenterB , MotleyT . The role of viscosupplementation in the ankle using hylan G‐F 20. The Journal of Foot and Ankle Surgery2008 Sep‐Oct;47(5):377‐84. [DOI: 10.1053/j.jfas.2008.06.013] ">Carpenter 2008</a>). <a href="./references#CD010643-bbs2-0014" title="AbateM , SchiavoneC , SaliniV . Hyaluronic acid in ankle osteoarthritis: why evidence of efficacy is still lacking?. Clinical and Experimental Rheumatology2012 Mar‐Apr;30(2):277‐81. [PUBMED: 22338615] ">Abate 2012</a> reviewed four randomised controlled trials—<a href="./references#CD010643-bbs2-0025" title="CarpenterB , MotleyT . The role of viscosupplementation in the ankle using hylan G‐F 20. The Journal of Foot and Ankle Surgery2008 Sep‐Oct;47(5):377‐84. [DOI: 10.1053/j.jfas.2008.06.013] ">Carpenter 2008</a>, <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>, <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>, <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a>—and five case series. No pooled analysis was performed. They concluded that there was no evidence on the efficacy of HA in reducing pain and improving function in ankle OA. Their advice for future research was to look at an adequate dose regimen, a good outcome measure, identify which patients and grade of OA benefit best of hyaluronic acid injections. </p> <p><a href="./references#CD010643-bbs2-0027" title="ChangKV , HsiaoMY , ChenWS , WangTG , ChienKL . Effectiveness of intra‐articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta‐analysis. Archives of Physical Medicine and Rehabilitation2013;94(5):951‐60. ">Chang 2013</a> included five randomised controlled trials (<a href="./references#CD010643-bbs2-0025" title="CarpenterB , MotleyT . The role of viscosupplementation in the ankle using hylan G‐F 20. The Journal of Foot and Ankle Surgery2008 Sep‐Oct;47(5):377‐84. [DOI: 10.1053/j.jfas.2008.06.013] ">Carpenter 2008</a>; <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0002" title="DeGrootH , UzunishviliS , WeirR , Al‐omariA , GomesB . Intra‐articular injection of hyaluronic acid is not superior to saline solution injection for ankle arthritis: a randomized, double‐blind, placebo‐controlled study. The Journal of Bone and Joint Surgery, American Volume2012;94(1):2‐8. [PUBMED: 22218376] ">DeGroot 2012</a>; <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>), one double arm and four single arm prospective studies. All studies were pooled based on improvement scores from baseline. A significant reduction in pain was found for HA injections based on the pooled effect size of improvement scores from baseline at three months, indicating that intra‐articular HA is an effective therapeutic approach for ankle OA. A not statistically significant difference was found in favour for HA comparing HA to placebo at three months. </p> <p><a href="./references#CD010643-bbs2-0050" title="MiglioreA , GiovannangeliF , BizziE , MassafraU , AlimontiA , LaganàB , Diamanti PicchiantiA , GermanoV , GranataM , PiscitelliP . Viscosupplementation in the management of ankle osteoarthritis: a review. Archives of Orthopaedic and Trauma Surgery2011 Jan;31(1):139‐47. [DOI: 10.1007/s00402‐010‐1165‐5] ">Migliore 2011</a> included four randomised trials (<a href="./references#CD010643-bbs2-0025" title="CarpenterB , MotleyT . The role of viscosupplementation in the ankle using hylan G‐F 20. The Journal of Foot and Ankle Surgery2008 Sep‐Oct;47(5):377‐84. [DOI: 10.1053/j.jfas.2008.06.013] ">Carpenter 2008</a>; <a href="./references#CD010643-bbs2-0001" title="CohenMM , AltmanRD , HollstromR , HollstromC , SunC , GipsonB . Safety and efficacy of intra‐articular sodium hyaluronate (Hyalgan) in a randomized, double‐blind study for osteoarthritis of the ankle. Foot and Ankle International2008;29(7):657‐63. [PUBMED: 18785414] ">Cohen 2008</a>; <a href="./references#CD010643-bbs2-0003" title="KaratosunV , UnverB , OzdenA , OzayZ , GunalI . Intra‐articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long‐term follow‐up. Clinical and Experimental Rheumatology2008;26(2):288‐294. [PUBMED: 18565251] ">Karatosun 2008</a>; <a href="./references#CD010643-bbs2-0004" title="SalkRS , ChangTJ , D'CostaWF , SoomekhDJ , GroganKA . Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double‐blind pilot study. Journal of Bone and Joint Surgery, American Volume2006;88(2):295‐302. [PUBMED: 16452740] ">Salk 2006</a>); and four single arm studies. Due to the heterogeneity of studies, data could not be pooled. Every study and the conclusion was described. The overall conclusion was that viscosupplementation is useful in ankle OA. Future prospective studies need to use standardised outcomes. </p> <p>The present review was restricted to an analysis of data from randomised controlled trials; only comparable data were pooled. It was found that at six months, which was our primary time point, HA is superior to placebo for the total AOS score (MD −12.53, 95% CI −23.84 to −1.22). However, this is based on low quality of evidence. No individual scores (AOS pain or disability) for this comparison at six months were available. It is not known if a mean difference of 12.53 points on a 100 point scale is clinically relevant. At three months, which we specified as an additional time point, the individual AOS pain and AOS disability score are inconclusive for the pooled analysis (as are the total AOS), due to a serious imprecision of results (studies are on opposite sides of null effect) and limitation in study design; this evidence was downgraded to very low quality. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010643-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010643-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010643-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010643-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 1 AOS total (combined pain and function score) at 6months." data-id="CD010643-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 1 AOS total (combined pain and function score) at 6months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 2 AOS total (combined pain and function score) at 3months." data-id="CD010643-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 2 AOS total (combined pain and function score) at 3months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 3 Pain (AOS pain) at 3months." data-id="CD010643-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 3 Pain (AOS pain) at 3months.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 4 Physical Function ( AOS disability) at 3months." data-id="CD010643-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 4 Physical Function ( AOS disability) at 3months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 5 Serious adverse events." data-id="CD010643-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 5 Serious adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 6 Any adverse events." data-id="CD010643-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 6 Any adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Hyaluronic acid versus Placebo, Outcome 7 Patients who withdraw because of an adverse event." data-id="CD010643-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Hyaluronic acid versus Placebo, Outcome 7 Patients who withdraw because of an adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 1 Pain during activity‐VAS." data-id="CD010643-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 1 Pain during activity‐VAS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 2 Physical Function_total AOFAS." data-id="CD010643-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 2 Physical Function_total AOFAS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 3 Walking distance (AOFAS)." data-id="CD010643-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Hyaluronic acid versus Exercise therapy, Outcome 3 Walking distance (AOFAS).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 1 Pain_AOS‐pain." data-id="CD010643-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 1 Pain_AOS‐pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 2 Physical Function_AOS‐disability." data-id="CD010643-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 2 Physical Function_AOS‐disability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010643-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/urn:x-wiley:14651858:media:CD010643:CD010643-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_t/tCD010643-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 3 Adverse events." data-id="CD010643-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Hyaluronic acid versus botulinum toxin A, Outcome 3 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/media/CDSR/CD010643/image_n/nCD010643-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010643-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyaluronic acid for osteoarthritis of the ankle</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hyaluronic acid for osteoarthritis of the ankle</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with osteoarthritis of the ankle<br/> <b>Settings:</b> Rehabilitation centre / hospital<br/> <b>Intervention:</b> hyaluronic acid<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Hyaluronic acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>AOS total (Pain &amp; Physical function)</b> <br/> AOS total score. Scale from: 0 to 100 (0 = being no pain/disability, 100 = worst imaginable pain/disability).<br/> Follow‐up: 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain/physical function change ranged across the control groups from 6.8 to 20.9 points lower with a weighted mean of<br/> <b>12.14 lower</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain/physical function in the hyaluronic acid group was <b>12.53 points lower</b> (23.84 lower to 1.22 lower) compared to placebo at 6 months. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A lower score indicates less pain and a better physical function. It is not known if a change of 12 points is clinically relevant. </p> <p>NNT = 4 (95% CI 2 to 205) (using a SMD = 0.5 as a minimum important difference).</p> <p>Absolute risk difference is −12.53% (95% CI −23.84 to −1.22).</p> <p>Relative percentage change is 1.85% (95% CI 0.18 to 3.58%).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Radiographic Joint Structure Changes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Radiographic joint structure changes were not investigated.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of Life</b> </p> <p>SF12. Scale from: 0 to 100. Follow‐up: mean 6 months.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45 (2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cohen 2008 only described that there was no significant difference between placebo and intervention for the SF12 outcome, no exact data was provided. </p> <p>Salk 2006 could not provide us with the standard deviations, so no estimate of the SF12 could be made. He demonstrated a statistically significant difference in his paper favouring hyaluronic acid at 6 months. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing any serious adverse events</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No serious adverse events (SAEs) were noted</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Number of participants experiencing any adverse event</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>43 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>35 per 1000</b> <br/> <b>higher</b> (26 fewer to 241 more) compared to placebo. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.66</b> <br/> (0.47 to 5.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Peto Odds Ratio is 2.34</p> <p>(95% CI 0.45 to 12.11)</p> <p>Absolute risk difference is 5.00% (−5 to 14), relative percentage change is 66% (−53% to 488%). </p> <p>Adverse events for all 3 studies were reported, even though DeGroot had a follow up of 3 months. All adverse events resolved within a week after injection, so a shorter follow up has no effect on the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participants who withdraw because of an adverse event or any other reason</b> <br/> <br/> Follow‐up: 3 to 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>109<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No participants withdrew because of an adverse event</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>AOS:</b> Ankle Osteoarthritis Scale<b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>SF12:</b> short form 12 </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>Grade criteria</b>: study limitation, indirectness, inconsistency, imprecision, publication bias. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>* The assumed risk was based on the weighted mean of the scores in the control groups across the 2 studies. The range was based on the mean change in pain on a visual analogue scale (100 mm) of the control group in each separate study.The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><sup>1</sup> Evidence was downgraded based on limitations in study design and imprecision of results. Limitation in study design: there was a unclear risk of selection bias for Salk and Cohen, unclear risk for attrition bias for Salk. Imprecision of results: the population size is small (45 participants). No indirectness of evidence was found, no inconsistency and no publication bias. </p> <p><sup>2</sup> Evidence was downgraded based on limitations in study design and imprecision of results. Limitation in study design: there was a unclear risk of selection bias for Cohen, an unclear risk for reporting bias for DeGroot. Imprecision of results: the total population size is small (92 participants). No indirectness of evidence was found, no inconsistency and no publication bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Hyaluronic acid for osteoarthritis of the ankle</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/full#CD010643-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010643-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hyaluronic acid versus Placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 AOS total (combined pain and function score) at 6months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.53 [‐23.84, ‐1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 AOS total (combined pain and function score) at 3months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.26 [‐11.23, 6.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain (AOS pain) at 3months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.83 [‐11.33, 7.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Physical Function ( AOS disability) at 3months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐9.26, 9.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Any adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [0.45, 12.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Patients who withdraw because of an adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hyaluronic acid versus Placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010643-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hyaluronic acid versus Exercise therapy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain during activity‐VAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐2.54, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Physical Function_total AOFAS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.1 [2.97, 23.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Walking distance (AOFAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.27, 0.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Hyaluronic acid versus Exercise therapy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010643-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Hyaluronic acid versus botulinum toxin A</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain_AOS‐pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.42, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Physical Function_AOS‐disability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.34, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.15, 6.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Hyaluronic acid versus botulinum toxin A</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010643.pub2/references#CD010643-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010643.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD010643-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD010643-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010643-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010643-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="pl#CD010643-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD010643-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010643\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010643\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010643\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010643\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010643\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=9mpoajSI&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010643.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010643.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010643.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010643.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010643.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728315293"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010643.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728315297"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010643.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec17c4fc5f46e',t:'MTc0MDcyODMxNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 